bismuth has been researched along with bismuth subsalicylate in 350 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 81 (23.14) | 18.7374 |
| 1990's | 143 (40.86) | 18.2507 |
| 2000's | 65 (18.57) | 29.6817 |
| 2010's | 45 (12.86) | 24.3611 |
| 2020's | 16 (4.57) | 2.80 |
| Authors | Studies |
|---|---|
| DuPont, HL; Ericsson, CD; Evans, DG; Evans, DJ; Pickering, LK | 1 |
| Gyles, CL; Zigler, M | 1 |
| Bird, N; Butcher, GP; Haqqani, MT; Hughes, SJ; Rhodes, JM; Ryder, SD; Stewart, M | 1 |
| Bär, W; Freise, J; Gebel, M; Gladziwa, U; Haruma, K; Lange, P; Schmidt, FW; Wagner, S | 1 |
| Cunha, BA; Domenico, P; O'Leary, R | 1 |
| Laine, L | 1 |
| Barkin, JS; Bernstein, D | 1 |
| Duriex, DE; Madan, E; Midkiff, BR; Subik, MA; Westblom, TU | 1 |
| Cave, DR | 1 |
| Gump, DW; Hendricks, GM; Meyer, DH; Nadeau, OW | 2 |
| Fraser, AG; Lam, WM; Luk, YW; Pounder, RE; Prewett, EJ | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Saeed, ZA | 1 |
| Treem, WR | 1 |
| Keystone, JS; Tellier, R | 1 |
| Glassman, MS | 1 |
| Alpert, LC; Evans, DG; Evans, DJ; Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM | 1 |
| Casaubón-Garcín, P; Cervantes, R; Ramírez-Mayans, J; Tovar-Calderón, S | 1 |
| Bär, W; Gebel, M; Haruma, K; Lange, P; Müller, MJ; Schorn, T; Soudah, B; Varrentrapp, M; Wagner, S | 1 |
| Sainsbury, SJ | 1 |
| Cunha, BA; Domenico, P; Landolphi, DR | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM | 1 |
| Alpert, LC; Evans, DG; Evans, DJ; Graham, DY; Jerdack, GR; Klein, PD; Morgan, DR; Opekun, A | 1 |
| Hudson, M; Nwokolo, CU; Pounder, RE; Prewett, EJ; Sawyerr, AM | 1 |
| Farthing, MJ | 1 |
| Bokemeyer, B; Freise, J; Fritsch, RS; Iserhard, R; Schmidt, FW; Soudah, B; Wagner, S; Weissbrodt, H | 1 |
| Avendaño, P; Balm, TK; Braun, SD; Manhart, MD; O'Ryan, M; Soriano, HA; Soriano-Brücher, H | 1 |
| Ali, MR; Blaser, MJ; Morris, AJ; Nicholson, GI; Perez-Perez, GI | 1 |
| Avunduk, C; Eastwood, GL; Gang, D; Polakowski, N; Suliman, M | 1 |
| Korsten, MA; Lateef, SK; Lieber, CS; Paronetto, F; Uppal, R | 1 |
| Campbell, AN | 1 |
| Arnold, HL | 1 |
| Jones, H; Rhodes, JM; Ryder, SD; Walker, RJ | 1 |
| Mistry, P; Nwokolo, CU; Pounder, RE | 1 |
| Chaparala, RC; Hakki, FZ; Harmon, JW; Huesken, J; Saini, N; Schweitzer, EJ; Tay, HP | 1 |
| Cruz Luna, A; DuPont, HL; DuPont, MW; Ericsson, CD; Flores Sanchez, J; Mathewson, JJ; Mendiola Gomez, J | 1 |
| Ferrell, L; Heyman, MB; Ostroff, JW; Veereman Wauters, G | 1 |
| Holtz, TH; Nettleman, MD | 1 |
| Islam, S; McLean, AJ | 1 |
| Hoffman, RS; Mendelowitz, PC; Weber, S | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Opekun, A | 1 |
| Burnett, JW | 1 |
| Hänninen, ML | 1 |
| Blessing, J; Raedsch, R; Walter-Sack, I; Weber, E | 1 |
| Appelman, HD; Cotner, EK; Elta, GH; Montbriand, JR; Nostrant, TT | 1 |
| Derksen, FJ; Evans, MG; Slocombe, RF | 1 |
| Bonamico, M; Carpino, F; Chiesa, C; Medici, A | 1 |
| Jakobsen, A; Ostergaard, K; Sommer, S; Steiness, E; Thorling, EB | 1 |
| Bayerdörffer, E; Mannes, GA; Pfaller, P; Sauerbruch, T | 1 |
| Olson, CA; Sox, TE | 1 |
| Bär, W; Freise, J; Fritsch, S; Schmidt, FW; Wagner, S | 1 |
| Barner, M; Emde, C; Hopert, R; Riecken, EO; Vallo-Wermes, M | 1 |
| Appelman, H; Barnett, JL; Behler, EM; Elta, GH; Kern, S; Murphy, R; Nostrant, TT | 1 |
| Lanza, FL; Rack, MF; Skoglund, ML; Yardley, JH | 1 |
| Kraus, JW; Morello, PJ | 1 |
| Hahn, H; Vogt, K; Warrelmann, M | 1 |
| Bästlein, C; Bayerdörffer, E; Kasper, G; Ottenjann, R; Simon, T | 1 |
| Balm, TK; DuPont, HL; Ericsson, CD; Helminger, A; Mathewson, JJ; Steffen, R; Witassek, F; Wolff, K | 1 |
| Shanbrom, E | 1 |
| Szap, MD | 1 |
| Alpert, LC; Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Michaletz, PA; Opekun, AR; Polasani, RR; Smith, KE; Yoshimura, HH | 1 |
| Börsch, G; Rühl, GH | 1 |
| Knowlton, DR; Sander, DS; Ward, RL | 1 |
| Dettmer, A; Eberhardt, R; Hagena, D; Höchter, W; Kasper, G | 1 |
| Börsch, G; Mai, U; Müller, KM | 1 |
| Baczako, K; Bode, G; Ditschuneit, H; Malfertheiner, P; Stanescu, A | 1 |
| Chiasson, D; Cutz, E; Drumm, B; Karmali, M; Sherman, P | 1 |
| DuPont, HL | 2 |
| Gregor, M; Hofmann, J; Menge, H | 1 |
| Daschner, F; Engels, I; Kappstein, I; Krieg, N; Pfisterer, J; Reuschenbach, K; Vogel, W | 1 |
| Baczako, K; Bode, G; Ditschuneit, H; Malfertheiner, P; Stanescu, A; Vanek, E | 1 |
| McNulty, CA | 1 |
| DuPont, HL; Helminger, A; Heusser, R; Manhart, MD; Schär, M; Steffen, R; Witassek, F | 1 |
| Girard, DE; Keeffe, EB | 1 |
| Andersen, LP; Andreasen, JJ | 1 |
| Engels, I; Kappstein, I | 1 |
| Rösch, W | 1 |
| Hughes, RJ | 1 |
| Bitsura, JA; de la Cabada, FJ; DuPont, HL; DuPont, MW; Ericsson, CD; Johnson, PC | 1 |
| León-Barúa, R; Tello-Casanova, R | 1 |
| Kreider, S; Lange, WR | 1 |
| Du Pont, HL | 1 |
| Grill, B; Gryboski, JD; Hillemeier, AC; Kocoshis, S | 1 |
| Graham, DY | 1 |
| Bitsura, JA; DuPont, HL; Ericsson, CD; Johnson, PC; Morgan, DR; Wood, LV | 1 |
| Turner, AC | 1 |
| Weiss, BD | 2 |
| Barriere, SL; Kapusnik, JE | 1 |
| Estes, MK; Gentry, LO; Graham, DY | 1 |
| Hailey, FJ; Newsom, JH | 1 |
| Feldman, M | 1 |
| Ghent, CN; Gryboski, JD; Kocoshis, SA | 1 |
| McIntyre, RV | 1 |
| Stek, M | 1 |
| Levine, RA | 1 |
| Boise, KL; Brooks, RR; Goldenberg, MM | 1 |
| Stillman, AE | 1 |
| Scott, D | 1 |
| Ackerman, PB; DuPont, HL; Ericsson, CD; Evans, DG; Evans, DJ; Pickering, LK; Sullivan, P; Tjoa, WS; Vollet, JJ | 1 |
| Cleary, TG; Ericsson, CD; Feldman, S; Pickering, LK | 2 |
| Marsh, AP; McPhee, MS | 1 |
| Duggan, JM; Hasking, GJ | 1 |
| Chen, SL; Cleary, TG; Ericsson, CD; Feldman, S; Hulse, M; Pickering, LK | 1 |
| Callahan, DR; Douglas, RG; Greenberg, HB; Steinhoff, MC | 1 |
| DuPont, HL; Ericsson, CD; Pickering, LK; Sullivan, P | 1 |
| Henderson, IW | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Wilson, WH | 1 |
| Appelman, HD; Barnett, JL; Behler, EM; Crause, I; Elta, GH; Nostrant, TT; Scheiman, JM | 1 |
| Asnicar, MA; Chong, SK; Croffie, JM; Fitzgerald, JF; Lee, CH; Lou, Q; Zimmerman, SE | 1 |
| Rampal, P; Scarpignato, C | 1 |
| Dwarakanath, AD; Hart, CA; Milton, JD; Rhodes, JM; Tsai, HH | 1 |
| Cohen, MH | 1 |
| Gallicano, K; Garber, G; Oliveras, L; Rambout, L; Sahai, J | 1 |
| Rhoads, JM | 1 |
| al-Assi, MT; Cole, RA; Genta, RM; Graham, DY; Karttunen, TJ | 1 |
| Allen, A; Copeman, M; Dettmar, PW; Leonard, AJ; Matuz, J; Pearson, JP | 1 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 1 |
| Abrams, RI; Barr, WB; Correa, DD; Gordon, MF; Rubin, DB | 1 |
| Campbell, DR; Cherian, R; McGregor, DH; Weston, AP | 1 |
| Graham, DY; Peura, DA | 1 |
| al-Assi, MT; Genta, RM; Graham, DY; Lew, GM; Ramirez, FC | 1 |
| Bleck, J; Gebel, M; Gladziwa, U; Haruma, K; Manns, M; Schmidt, H; Soudah, B; Wagner, S | 1 |
| Höök-Nikanne, J; Kosunen, TU; Roine, RP; Salaspuro, M; Salmela, KS | 1 |
| Berman, D; George, J; Groisman, GM; Harpaz, N | 1 |
| McGuffey, EC | 1 |
| Bellucci, AG; Vernace, MA; Wilkes, BM | 1 |
| Börsch, G; Labenz, J | 1 |
| Correa, P; Fontham, ET; Hunter, FM; Johnson, WD; Malcom, GT; Rood, JC; Ruiz, B; Sobhan, M | 1 |
| Jungreis, AC; Schaumburg, HH | 1 |
| Brazer, SR; Maniatis, AG | 1 |
| Genta, RM; Go, MF; Graham, DY; Lew, GM; Rehfeld, JF | 1 |
| Correa, P; Fontham, E; Hunter, FM; Ruiz, B; Samloff, IM; Sobhan, M | 1 |
| Abramson, JS; Givner, LB; Woods, CR | 1 |
| Guiraldes, E | 1 |
| Levy, G | 1 |
| Graham, DY; Hepps, KS; Lew, GM; Ramirez, FC; Saeed, ZA | 1 |
| Hassall, E; Israel, DM | 1 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 2 |
| Cohen, H; Dooley, CP; Field, LG; Frierson, HF; Guerrant, RL; Jerdack, GR; Marshall, BJ; McCallum, RW; Mitra, S; Valenzuela, JE | 1 |
| Fedotin, MS | 1 |
| Cutler, AF; Schubert, TT | 1 |
| Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Ramirez, FC | 1 |
| Campos-Sánchez, M; Eyzaguirre-Maccan, E; Figueroa-Quintanilla, D; León-Barúa, R; Sack, RB; Salazar-Lindo, E; Sarabia-Arce, S | 1 |
| Snyder, JD | 1 |
| Bästlein, E; Bayerdörffer, E; Heldwein, W; Höchter, W; Lehn, N; Mannes, GA; Miehlke, S; Müller-Lissner, S; Sommer, A; Weingart, J | 1 |
| Burrow, JA; Clark, CK; Merritt, AM; Steible, CK | 1 |
| Horowitz, NS; Palker, TJ; Staats, HF | 1 |
| Acuña, R; Albornoz, V; Figueroa, G; Portell, DP; Toledo, MS; Troncoso, M; Vigneaux, J | 1 |
| Tytgat, GN | 1 |
| Bästlein, E; Bayerdörffer, E; Bolle, KH; Hatz, R; Heldwein, W; Höchter, W; Klann, H; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Ruckdeschel, G; Simon, T; Sommer, A; Stolte, M; Weingart, J | 1 |
| Fuhrer, J; Hearney, EG; Marioz, P | 1 |
| Behler, EM; Chey, WD; Crause, I; Elta, GH; Scheiman, JM | 1 |
| Bästlein, E; Bayerdörffer, E; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Stolte, M | 1 |
| Carmichael, JM; Patchin, GM; Wieland, KA | 1 |
| Freston, JW; Murphy, K; Taylor, JL; Zagari, M | 1 |
| Brown, PW; Chang, J; Hwang, KK; Rao, N; Yerino, P | 1 |
| Seifrit, B | 1 |
| Lambert, JR; Midolo, P | 1 |
| Damianos, AJ; McGarrity, TJ | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Angeletti, S; Annibale, B; Bordi, C; Delle Fave, G; Malagnino, F; Mancino, C; Marignani, M | 1 |
| Danziger, LH; Meyer, JM; Pendland, SL; Ryu, S | 1 |
| Carryl, OR; Guth, PH; Kaunitz, JD; Tanaka, S | 1 |
| Myers, D | 1 |
| Contreras-Ruiz, J; Guevara-Flores, A; López-Corella, E; Ruiz-Maldonado, R; Sierra-Santoyo, A | 1 |
| Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM | 1 |
| Bagchi, D; Bagchi, M; Carryl, OR; Krohn, RL; Mitra, S; Ray, SD; Stohs, SJ; Tran, MX; Vuchetich, PJ | 1 |
| El-Zaatari, F; Engstrand, L; Genta, RM; Graham, D; Scheynius, A | 1 |
| el-Zimaity, HM; Graham, DP; Graham, DY; Hoffman, J; Osato, M | 1 |
| Eaton, KA; Kramer, LW; Wack, RF | 1 |
| Batchelder, M; Fox, JG; Hayward, A; Murphy, JC; Palley, L; Shames, B; Yan, L | 1 |
| Bierman, JC; Blanchard, TG; Czinn, SJ; Diters, RW; Leunk, RD | 1 |
| Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
| Minocha, A; Srinivasan, R | 1 |
| Carrazco, J; Checkley, W; Cordero, L; Gilman, RH; Leon-Barua, R; McDonald, J; Ramirez-Ramos, A; Recavarren-Arce, S; Salazar, G; Valdez, Y; Watanabe, J | 1 |
| Clendening, CE; Dansereau, RJ; Deepe, GS; Dunn, AB; Healy, DP; Mounts, AW | 1 |
| Fine, KD; Lee, EL | 1 |
| Berg, DE; Blaser, MJ; Dubois, A; Fiala, N; Heman-Ackah, LM; Perez-Perez, GI | 1 |
| Ariano, RE; Tkach, CL | 1 |
| Furne, JK; Levitt, MD; Springfield, J; Suarez, FL | 1 |
| Ericsson, CD | 1 |
| Carryl, OR; Illich, PA; Lichtenberger, LM; Romero, JJ; Walters, ET | 1 |
| Fitzgerald, JF; Troncone, R | 1 |
| Ahsan, K; Hadjiyane, C; Karakurum, A; Mohammed, I; Nawaz, A; Pellecchia, C | 1 |
| Bellin, EY; Fletcher, DD; Shuter, J; Simone, VJ | 1 |
| Bello, H; Dominguez, M; Gonzalez, G; Martínez, MA; Mella, S; Pinto, ME; Ruiz, M; Sepulveda, M; Zemelman, R | 1 |
| Surawicz, C | 1 |
| DiBaise, JK; Dy, RM; Lof, J; Quigley, EM | 1 |
| Blanchard, J; Boden, J; Ermak, T; Georgakopoulos, K; Giannasca, P; Gray, H; Hill, J; Ingrassia, J; Kleanthous, H; Lee, CK; Monath, TP; Soike, K; Tibbitts, T; Weltzin, R | 1 |
| Anderson, SY; Graham, DY; Lang, T | 1 |
| Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL | 1 |
| Cabanillas, FF; Ford, R; Genta, RM; Glober, G; Graham, DY; Hagemeister, FB; Johnson, CM; Lahoti, S; Lee, JE; Luthra, R; Lynch, PM; Manning, JT; McLaughlin, PW; Rodriguez, MA; Romaguera, JE; Sample, D; Sarris, AH; Shen, Y; Steinbach, G; Winn, RJ; Younes, A | 1 |
| Fendrich, Z | 1 |
| Bagchi, D; Bagchi, DJ; Bagchi, M; Balmoori, J; Carryl, OR; Garg, A; Milnes, MM; Mitra, S; Stohs, SJ; Tran, MX; Williams, CB | 1 |
| Bravo, LE; Campo, C; Correa, P; Mera, R; Realpe, JL | 1 |
| Coyle, WJ; Duntemann, T; Lawson, JM; Murphy, M; Nemec, R; Peterson, R; Sedlack, RE | 1 |
| Canning, A; Egan, C; Farraye, FA; Kemp, JA; Lee, M; Tataronis, G | 1 |
| Schiller, LR | 2 |
| Shlim, DR | 1 |
| Dubois, A; Heman-Ackah, LM; Mysore, JV; Simon, PM; Wigginton, T; Zopf, D | 1 |
| Alonso García, I; García Pérez, A; Giménez Samper, M; Valverde de La Osa, J | 1 |
| Bagchi, D; Bagchi, M; Balmoori, J; Carryl, OR; Kuszynski, CA; McGinn, TR; Mitra, S; Stohs, SJ; Ye, X | 1 |
| Gurer, I; Hilmioglu, F; Ozyilkan, E; Sare, M; Taskin, V | 1 |
| Bravo, JC; Bravo, LE; Correa, P; Realpe, JL; Ruiz, B; van Doorn, LJ | 1 |
| Brousal, A; Kearney, DJ | 1 |
| Cleary, CE; Malatjalian, DA; Peterson, TC; Shaw, AM; Veldhuyzen van Zanten, SJ | 1 |
| Bisson, S; Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Opekun, AR; Osato, MS | 1 |
| Ewing, SL; Furne, JK; Levitt, MD; Springfield, J; Suarez, FL | 1 |
| Furne, J; Garten, C; Levitt, MD; Stiehm, J; Suarez, FL | 1 |
| Amaro, R; Poniecka, A; Rogers, AI | 1 |
| Levitt, MD; Suarez, FL | 1 |
| García, A; González, C; Solar, H; Zemelman, R | 1 |
| Devitt, NF | 1 |
| Chiba, N | 1 |
| El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Osato, MS; Saeed, MA | 1 |
| Bravo, JC; Bravo, LE; Casabon, AL; Collazos, T; Correa, P; Fischbach, LA; Ramirez, H; Realpe, JL; Ruiz, B; Schmidt, BA | 1 |
| Bruzzese, E; Guarino, A | 1 |
| Chowdhury, HR; Faruque, SM; Lescano, AG; Rahman, A; Sack, RB; Yunus, M; Zaman, K | 1 |
| Adams, DR; Gordon, CA; Ioffreda, MD; Miller, JJ; Naides, SJ | 1 |
| Corder, FA; Howden, CW; Sahai, AV; Sharma, VK | 1 |
| Kollaritsch, H; Rendi-Wagner, P | 1 |
| Amsler, KM; Foster, LA; Merrill, JJ; Modzelewski, TC; Quispe, JD; Sizemore, CF; Slee, AM; Stevenson, DA | 1 |
| Takahashi, S; Tanaka, A | 1 |
| Hagan, L; Johns, J; More, D; Whisman, B | 1 |
| Fölsch, UR; Hellmig, S; Katsoulis, S; Stüber, E | 1 |
| Michetti, P; Suerbaum, S | 1 |
| Marlier, EM; Thurston, JH; Whitmire, KH | 1 |
| Chande, N; MacDonald, JK; McDonald, JW | 5 |
| Abdo, AA; Beck, PL; Urbanski, SJ | 1 |
| Correa, P; Feldman, M; Fischbach, LA; Fontham, E; Goodman, KJ; Jain, R; Priest, E | 1 |
| Nielsen, OH; Schaffalitzky de Muckadell, OB | 1 |
| Cisneros, G; Gurney, M; Jarjoura, D; Lara, LF; Moauro, B; Polen, A; Rutecki, G; Van Ness, M; Whittier, F | 1 |
| PARDO, OA; PARDO-CASTELLO, V | 2 |
| KOLMER, JA | 2 |
| HARRINGTON, CM; PAUL, HE | 1 |
| PARDO CASTELLO, V; PARDO, OA | 1 |
| Bacon, K; Deveney, C; Gilster, J; Marlink, K; Rutten, M; Sheppard, B | 1 |
| Abudayyeh, S; Belson, G; Dore, MP; El-Zimaity, HM; Graham, DY; Osato, MS | 1 |
| Burford, N; Eelman, MD; Mahony, DE; Veldhuyzen van Zanten, SJ; Woods, A | 1 |
| Dodge, AG; Wackett, LP | 1 |
| Banks, JB; Devitt, N | 1 |
| Aeed, H; Avni, Y; Birkenfeld, S; Eliakim, R; Levine, A; Shabat-Sehayek, V; Shevah, O; Shirin, H; Wardi, J | 1 |
| Sun, XM; Yang, ZM | 1 |
| Badillo, R; Hagemann, TM; Lewis, TV; McGoodwin, L; Schaeffer, S | 1 |
| Hanjani, NM; Rencic, A; Whitmore, SE | 1 |
| DuPont, HL; Koo, HL | 1 |
| Andrews, PC; Deacon, GB; Forsyth, CM; Junk, PC; Kumar, I; Maguire, M | 1 |
| Choe, YH; Choi, J; Jang, JY; Kim, JS; Kim, KM; Park, HY | 1 |
| Fagin, B; Feeman, W; Lash, A; Wismer, T | 1 |
| Page, MJ; Schirmer, LL; Wall, GC | 1 |
| Burford, N; Eelman, MD; Phillips, HA | 1 |
| Harper, DS | 1 |
| Birkenfeld, G | 1 |
| Bravo, JC; Bravo, LE; Camargo, MC; Ceron, C; Correa, P; Delgado, AG; Fontham, ET; Mera, RM; Piazuelo, MB; Yepez, MC | 1 |
| Flint, KP; Naghdi, S; Raheb, J | 1 |
| Sökeland, J | 1 |
| Dunzendorfer, T; Johnson, R; Wilkins, S | 1 |
| Kurtz, SM; Manley, MM; Rimnac, CM; Sobieraj, MC; Wang, A | 1 |
| Archer, LL; Atkins, A; Childress, AL; Citino, SB; Fraser, WA; Wellehan, JF | 1 |
| Redfield, D; Singh, E | 1 |
| Wang, WQ; Zhang, QH; Zhu, BM | 1 |
| Cohen, PR | 1 |
| Gutierrez, AM; Jhala, N; Malik, TA; Peter, S | 1 |
| HILL, JS; SCHMITZ, RE | 1 |
| EAGLE, H | 1 |
| LEWIS, GM | 1 |
| Chey, WD; Malfertheiner, P; Vakil, N | 1 |
| GROSSMAN, HD | 2 |
| George, AE; Hildebrandt, E; Horton, KE; McGee, DJ; Testerman, TL; Trainor, EA | 1 |
| Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S | 1 |
| André, V; Curfs, C; Duarte, MT; Duer, MJ; Friščić, T; Halasz, I; Hardeman, A; Jackson, GJ; Reid, DG; Stein, RS | 1 |
| Başer, O; Emer, O; Kadayifci, A; Kantarcioğlu, M; Kılcıler, G; Ozcan, A; Polat, Z; Uygun, A | 1 |
| Fu, Y; Gao, DW; Jones, EF; Mongan, J; Rathnayake, S; Wang, R; Yeh, BM | 1 |
| Tack, J | 1 |
| Wenzl, HH | 1 |
| Adler, M; Dinh, C; Gray, LV; Gutierrez, A; Lu, B; Lukomnik, J; Marton, S; Mirabal, Y; Oden, M; Richards-Kortum, R; Schutze, GE; Shah, K; Slough, T; Spiegel, GJ; Wickham, H; Yeh, PT | 1 |
| Balasanthiran, V; Chisholm, MH; Durr, CB; Gallucci, JC | 1 |
| Abbas, Z; Awan, S; Hamid, S; Jafri, F; Jafri, W; Naz, S; Usman, MW; Yakoob, J | 1 |
| Goldman, RD | 1 |
| Bingham, AL; Brown, RO; Dickerson, RN | 1 |
| Bełtowski, J; Gertler, A; Jamroz-Wiśniewska, A; Solomon, G; Whiteman, M; Wood, ME | 1 |
| Blaine, ET; Johnson, AL; Lewis, AD | 1 |
| Mahachai, V; Siramolpiwat, S; Srinarong, C; Vilaichone, RK; Wongcha-um, A | 1 |
| Britt, TJ; Gross, WR; Montgomerie, SA; Van Metre, RM | 1 |
| Boissy, YL; Lee, D; Park, GW; Pitz, AM; Vinjé, J | 1 |
| Heather, CS | 1 |
| Chan, AT; Colussi, D; Khalili, H; Lauwers, GY; Ricciardiello, L; Richter, JR; Salari, B; Stewart, KO | 1 |
| Mahachai, V; Prapitpaiboon, H; Vilaichone, RK | 1 |
| Ataseven, H; Baglıcakoglu, M; Biyik, M; Demir, A; Goktepe, H; Gungor, G; Kayacetin, E; Ucar, R | 1 |
| Cartowski, J; Dart, A; Gupta, A; Gupta, S; Nelson, C; Poddar, A; Ravi, BS; Sheele, J; Stashko, E | 1 |
| Chaithongrat, S; Gamnarai, P; Mahachai, V; Namtanee, J; Prapitpaiboon, H; Vilaichone, RK; Wongcha-um, A | 1 |
| Geboes, K; Jauregui-Amezaga, A; Vermeire, S | 1 |
| Binversie, E; Fessenden, SW; Ruiz-Moreno, M; Stern, MD | 1 |
| Giddings, SL; Leung, DT; Stevens, AM | 1 |
| Fallone, CA; Shaikh, T | 1 |
| Barton, LL; Lin, DM; Lin, HC; Ritz, NL; Wilson, MR | 1 |
| Abbasi, J | 1 |
| Goldberg, D; King, MA; Parker, V | 1 |
| Al Yatama, N; Bhanji, T; Chande, N; MacDonald, JK; McDonald, JW; Nguyen, TM | 1 |
| Almaguer-Flores, A; Aztatzi-Aguilar, OG; Camps, E; De Vizcaya-Ruiz, A; Flores-Castañeda, M; Uribe-Ramírez, M; Vega-Jiménez, AL | 1 |
| Chande, N; Kafil, TS; MacDonald, JK; McDonald, JW; Nguyen, TM; Patton, PH | 1 |
| Göktaş, Z; Kahramanoğlu Aksoy, E; Nazlıgül, Y; Pirinçci Sapmaz, F; Uzman, M | 1 |
| Coşkun, DÖ; Deniz, K; Gürsoy, Ş; Özbakir, Ö; Yagbasan, A; Yücesoy, M | 1 |
| Alpert, L; Colussi, D; Khalili, H; Lauwers, GY; Misdraji, J; Setia, N; Stewart, KO; van der Sloot, KW | 1 |
| Robotis, J; Rokkas, T; Tsiodras, S | 1 |
| Chalkias, S; Edwards, MR; Koulinska, I; Riester, K | 1 |
| Calello, DP; Eustaquio, N; Nelson, LS; Ruck, BE; Santos, C; Yu, C | 1 |
| Hon, KL; Leung, AAM; Leung, AKC; Wong, AHC | 1 |
| Agboatwalla, M; Bowen, A; Brum, J; Pitz, A; Plikaytis, B; Salahuddin, S | 1 |
| Borbinha, C; Salavisa, M; Serrazina, F; Viana-Baptista, M | 1 |
| Balderas-López, JL; Bernad-Bernad, MJ; Medina-Torres, L; Navarrete, A; Orona-Ortiz, A; Pineda-Peña, EA; Tavares Carvalho, JC; Velázquez-Moyado, JA | 1 |
| Cogdill, AG; Guevara, B | 1 |
| Rubin, DT; Wolf, CH; Wolf, DC | 1 |
| Connor, BA; Martin, GJ; Riddle, MS | 1 |
| Araujo, RC; Ciriaco, FM; DiLorenzo, N; Dubeux, JCB; Fontes, PLP; Garcia-Ascolani, ME; Henry, DD; Lamb, GC; Mejia-Turcios, SE; Oosthuizen, N; Rostoll-Cangiano, L; Schulmeister, TM | 1 |
| Araujo, RC; Ciriaco, FM; Cliff Lamb, G; DiLorenzo, N; Dubeux, JCB; Fontes, PLP; Henry, DD; Oosthuizen, N; Rostoll-Cangiano, L; Sanford, CD; Schulmeister, TM | 1 |
| Balan, G; Brum, JM; Gibb, RD; Ramsey, DL; Yacyshyn, BR | 1 |
| Halani, S; Wu, PE | 1 |
| Liang, D; Ma, J; Wei, B | 1 |
| Janssens, L; Ji, H; Khanna, S | 1 |
| Almaguer-Flores, A; Clemente, I; Prado-Prone, G; Rodil, SE; Silva-Bermudez, P; Velasquillo, C; Vidal-Gutiérrez, X | 1 |
| Alaa Eddin, K; Alassi, MW; Alhalabi, M; Cheha, K | 1 |
| Araujo, RC; Ciriaco, FM; DiLorenzo, N; Dubeux, JCB; Henry, DD; Johnson, BJ; Mejia-Turcios, SE; Osorio-Doblado, AM; Sarturi, JO; Urso, PM; Woerner, DR | 1 |
| Arhangelskis, M; Bazhenov, V; Chaumont, D; Del Carmen Marco de Lucas, M; Dippel, AC; Do, JL; Friščić, T; Geoffroy, N; Glaevecke, P; Gutowski, O; Halasz, I; Hudspeth, JM; Ivashko, O; Kimber, SAJ; Meyer, M; Mouhtadi, S; Rousselin, Y; Schwanen, V; Spoerk-Erdely, P; Szczerba, D; Tan, D; Titi, HM | 1 |
| Inge, AK; Nero, M; Rooth, V; Svensson Grape, E; Willhammar, T | 1 |
| Calello, DP; Meaden, CW | 1 |
| Heimer, MM; Yeh, BM | 1 |
48 review(s) available for bismuth and bismuth subsalicylate
| Article | Year |
|---|---|
Therapeutic approaches to recurrent peptic ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Recurrence; Salicylates | 1992 |
Chronic nonspecific diarrhea of childhood.
Topics: Bismuth; Body Water; Breath Tests; Child, Preschool; Chronic Disease; Diagnosis, Differential; Diarrhea, Infantile; Dicyclomine; Dietary Carbohydrates; Fruit; Gastrointestinal Motility; Humans; Infant; Infant, Newborn; Intestinal Diseases, Parasitic; Lactose Intolerance; Loperamide; Malabsorption Syndromes; Myoelectric Complex, Migrating; Organometallic Compounds; Salicylates | 1992 |
Prevention of traveler's diarrhea.
Topics: Anti-Bacterial Agents; Bismuth; Diarrhea; Food Microbiology; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology; Water Supply | 1992 |
Helicobacter pylori infection in children. A clinical overview.
Topics: Anti-Bacterial Agents; Biopsy; Bismuth; Child; Clinical Trials as Topic; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Evaluation Studies as Topic; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Prevalence; Salicylates | 1992 |
[Helicobacter pylori: can it be a contributing factor in peptic ulcer in childhood?].
Topics: Anti-Bacterial Agents; Bismuth; Child; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1991 |
Review article: prevention and treatment of travellers' diarrhoea.
Topics: Anti-Bacterial Agents; Bismuth; Diarrhea; Diet; Fluid Therapy; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel | 1991 |
Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
Topics: Adolescent; Adult; Bismuth; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Humans; Middle Aged; Organometallic Compounds; Salicylates | 1987 |
[Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
Topics: Bismuth; Campylobacter Infections; Chronic Disease; Dose-Response Relationship, Drug; Gastritis; Humans; Organometallic Compounds; Salicylates | 1987 |
Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bismuth; Campylobacter Infections; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Diarrhea, Infantile; Drug Combinations; Dysentery, Amebic; Dysentery, Bacillary; Escherichia coli Infections; Giardiasis; Humans; Infant; Kaolin; Loperamide; Narcotics; Organometallic Compounds; Parasympatholytics; Pectins; Salicylates; Salmonella Infections; Travel | 1985 |
Traveler's diarrhea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Campylobacter Infections; Diarrhea; Diet; Dysentery, Bacillary; Escherichia coli Infections; Fluid Therapy; Giardiasis; Humans; Intestines; Organometallic Compounds; Risk; Salicylates; Salmonella Infections; Time Factors; Travel; Vaccination; Vibrio Infections; Vibrio parahaemolyticus | 1984 |
Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.
Topics: Anti-Bacterial Agents; Antibiosis; Antidiarrheals; Bismuth; Clinical Trials as Topic; Diarrhea; Feeding Behavior; Fluid Therapy; Food Microbiology; Humans; Lactobacillus; Organometallic Compounds; Salicylates; Travel; Water Microbiology; Water Supply | 1995 |
Treating peptic ulcer: an ongoing challenge.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline | 1995 |
Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Ranitidine; Salicylates; Stomach; Stomach Neoplasms | 1994 |
Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States | 1994 |
Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1993 |
Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Monte Carlo Method; Organometallic Compounds; Patient Compliance; Proton Pump Inhibitors; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1997 |
Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
The actions of bismuth in the treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bismuth; Drug Synergism; Duodenum; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Organometallic Compounds; Ranitidine; Salicylates; Treatment Outcome | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
[Common gastrointestinal symptoms and their effective and safe treatment].
Topics: Bismuth; Cathartics; Dioctyl Sulfosuccinic Acid; Gastrointestinal Diseases; Humans; Organometallic Compounds; Psyllium; Salicylates | 1999 |
Traveler's diarrhea.
Topics: Antibiotic Prophylaxis; Behavior Therapy; Bismuth; Diagnosis, Differential; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel; Vaccines | 1999 |
An understanding of excessive intestinal gas.
Topics: Bismuth; Charcoal; Diagnosis, Differential; Eructation; Flatulence; Humans; Organometallic Compounds; Salicylates | 2000 |
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; MEDLINE; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Risk Factors; Salicylates; Sensitivity and Specificity | 2001 |
[Classic triple therapy for Helicobacter pylori infection].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 2002 |
Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Proton Pump Inhibitors; Ranitidine; Salicylates; Virulence | 2002 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis; Collagen; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2002 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Diarrhea; Humans; Organometallic Compounds; Salicylates | 2003 |
Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and management.
Topics: Algorithms; Antidiarrheals; Bismuth; Budesonide; Colitis; Humans; Organometallic Compounds; Salicylates; T-Lymphocytes | 2003 |
Interventions for treating collagenous colitis: a Cochrane Inflammatory Bowel Disease Group systematic review of randomized trials.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chi-Square Distribution; Colitis, Collagenous; Double-Blind Method; Humans; Organometallic Compounds; Prednisolone; Randomized Controlled Trials as Topic; Salicylates | 2004 |
Travellers' diarrhoea: contemporary approaches to therapy and prevention.
Topics: Anti-Bacterial Agents; Antidiarrheals; Azithromycin; Bismuth; Campylobacter; Clinical Trials as Topic; Diarrhea; Drug Resistance, Bacterial; Escherichia coli; Food Microbiology; Humans; Hygiene; Organometallic Compounds; Rifamycins; Rifaximin; Salicylates; Shigella; Travel; Water Microbiology | 2006 |
Current and future developments in travelers' diarrhea therapy.
Topics: Bismuth; Diarrhea; Fluid Therapy; Humans; Organometallic Compounds; Probiotics; Rifamycins; Rifaximin; Risk Factors; Salicylates; Travel | 2006 |
Interventions for treating lymphocytic colitis.
Topics: Antidiarrheals; Bismuth; Colitis, Lymphocytic; Humans; Organometallic Compounds; Salicylates | 2007 |
Pharmacotherapy for microscopic colitis.
Topics: Adrenal Cortex Hormones; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Microscopic; Humans; Loperamide; Organometallic Compounds; Salicylates; Treatment Outcome | 2007 |
[Treating travelers' diarrhea. When should medication be given?].
Topics: Adult; Anti-Bacterial Agents; Atropine; Bismuth; Child; Cross-Sectional Studies; Diphenoxylate; Drug Combinations; Dysentery; Fluid Therapy; Fluoroquinolones; Humans; Loperamide; Organometallic Compounds; Probiotics; Risk Factors; Salicylates; Travel | 2007 |
Interventions for treating lymphocytic colitis.
Topics: Antidiarrheals; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Lymphocytic; Humans; Mesalamine; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2008 |
Prophylaxis for travelers' diarrhea.
Topics: Antibiotic Prophylaxis; Antidiarrheals; Bismuth; Diarrhea; Disinfection; Fluid Therapy; Food Contamination; Food Microbiology; Humans; Hygiene; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology | 2009 |
Black tongue secondary to bismuth subsalicylate: case report and review of exogenous causes of macular lingual pigmentation.
Topics: Bismuth; Humans; Hyperpigmentation; Male; Middle Aged; Organometallic Compounds; Salicylates; Tongue Diseases | 2009 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Stomach Neoplasms; Tetracycline | 2011 |
Functional diarrhea.
Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Bismuth; Carbon; Cholestyramine Resin; Chronic Disease; Clonidine; Diarrhea; Humans; Octreotide; Organometallic Compounds; Oxides; Probiotics; Receptors, Opioid; Salicylates; Serotonin 5-HT3 Receptor Antagonists; Thiorphan | 2012 |
Diarrhea in chronic inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Bacterial Infections; Biopsy; Bismuth; Blood Cell Count; Blood Chemical Analysis; Body Water; Breath Tests; Budesonide; Cholestyramine Resin; Colitis, Microscopic; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Endoscopy, Gastrointestinal; Feces; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Absorption; Intestinal Fistula; Intestinal Mucosa; Intestines; Ion Transport; Malabsorption Syndromes; Medical History Taking; Mesalamine; Organometallic Compounds; Physical Examination; Postoperative Complications; Prednisolone; Salicylates; Sodium; Tumor Necrosis Factor-alpha | 2012 |
Travellers' diarrhoea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Diarrhea; Diet; Fluid Therapy; Humans; Organometallic Compounds; Salicylates; Thiorphan; Travel-Related Illness | 2015 |
Contemporary methods for the diagnosis and treatment of microscopic colitis.
Topics: Anti-Inflammatory Agents; Antidiarrheals; Bismuth; Budesonide; Colitis, Microscopic; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Organometallic Compounds; Probiotics; Risk Factors; Salicylates; Tumor Necrosis Factor-alpha | 2016 |
Traveler's Diarrhea.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antidiarrheals; Arthritis, Reactive; Bismuth; Dehydration; Diarrhea; Female; Fluid Therapy; Foodborne Diseases; Guillain-Barre Syndrome; Humans; Immunocompromised Host; Irritable Bowel Syndrome; Organometallic Compounds; Pregnancy; Probiotics; Risk Factors; Salicylates; Travel; Travel Medicine; Vaccines; Waterborne Diseases | 2016 |
Interventions for treating lymphocytic colitis.
Topics: Anti-Inflammatory Agents; Antidiarrheals; Beclomethasone; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Lymphocytic; Humans; Mesalamine; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2017 |
Interventions for treating collagenous colitis.
Topics: Bismuth; Boswellia; Budesonide; Cholestyramine Resin; Chronic Disease; Colitis, Collagenous; Diarrhea; Glucocorticoids; Humans; Mesalamine; Organometallic Compounds; Plant Extracts; Prednisolone; Probiotics; Randomized Controlled Trials as Topic; Salicylates | 2017 |
Travelers' Diarrhea: A Clinical Review.
Topics: Anti-Bacterial Agents; Azithromycin; Bismuth; Dehydration; Developing Countries; Dysentery; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Food Contamination; Health Knowledge, Attitudes, Practice; Humans; Loperamide; Organometallic Compounds; Patient Education as Topic; Salicylates | 2019 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.
Topics: Bismuth; Communicable Diseases; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 2021 |
79 trial(s) available for bismuth and bismuth subsalicylate
| Article | Year |
|---|---|
Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
Topics: Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Time Factors | 1992 |
Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.
Topics: Bismuth; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Pain Measurement; Salicylates | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Risk Factors; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates | 1991 |
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Single-Blind Method; Tetracycline | 1991 |
The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Humans; Intestinal Absorption; Male; Organometallic Compounds; Placebos; Ranitidine; Receptors, Histamine H2; Salicylates | 1991 |
Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study.
Topics: Acute Disease; Bismuth; Child, Preschool; Diarrhea, Infantile; Double-Blind Method; Escherichia coli Infections; Feces; Fluid Therapy; Humans; Infant; Length of Stay; Organometallic Compounds; Rotavirus Infections; Salicylates | 1991 |
Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori.
Topics: Adult; Alcoholism; Aluminum Hydroxide; Amoxicillin; Bismuth; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Salicylates; Temperance | 1991 |
Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea.
Topics: Acute Disease; Adult; Bismuth; Clinical Trials as Topic; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Loperamide; Male; Nonprescription Drugs; Organometallic Compounds; Piperidines; Salicylates | 1990 |
[Epidemiology and therapy of Campylobacter pylori infection].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Drug Evaluation; Drug Therapy, Combination; Duodenum; Female; Gastrointestinal Diseases; Gastroscopy; Germany, West; Humans; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Salicylates; Stomach | 1989 |
[The effect of a calcium carbonate-bismuth subsalicylate combination on intragastric acidity over the course of 24 hours. A randomized study of healthy probands].
Topics: Adult; Bismuth; Calcium Carbonate; Circadian Rhythm; Drug Therapy, Combination; Female; Gastric Acidity Determination; Humans; Male; Organometallic Compounds; Salicylates | 1989 |
The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
Topics: Bismuth; Campylobacter; Campylobacter Infections; Gastritis; Humans; Organometallic Compounds; Prospective Studies; Random Allocation; Salicylates | 1989 |
Bismuth/ofloxacin combination for duodenal ulcer.
Topics: Anti-Infective Agents; Bismuth; Campylobacter Infections; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Humans; Ofloxacin; Organometallic Compounds; Oxazines; Random Allocation; Salicylates | 1987 |
Travelers' diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy.
Topics: Aeromonas; Africa, Western; Animals; Bismuth; Cryptosporidium; Diarrhea; Entamoeba histolytica; Escherichia coli; Feces; Female; Giardia; Humans; Male; Mexico; Organometallic Compounds; Salicylates; Shigella; Specimen Handling; Travel | 1988 |
[Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
Topics: Adult; Aged; Bismuth; Campylobacter; Campylobacter Infections; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Recurrence; Salicylates; Stomach Ulcer; Wound Healing | 1988 |
Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
Topics: Adolescent; Adult; Bismuth; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Humans; Middle Aged; Organometallic Compounds; Salicylates | 1987 |
Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Patient Compliance; Salicylates; Salmonella enteritidis; Shigella dysenteriae; Tablets; Travel | 1986 |
Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate.
Topics: Adult; Bismuth; Diarrhea; Humans; Mexico; Organometallic Compounds; Probability; Random Allocation; Salicylates; Tablets; Travel | 1987 |
Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bismuth; Campylobacter Infections; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Diarrhea, Infantile; Drug Combinations; Dysentery, Amebic; Dysentery, Bacillary; Escherichia coli Infections; Giardiasis; Humans; Infant; Kaolin; Loperamide; Narcotics; Organometallic Compounds; Parasympatholytics; Pectins; Salicylates; Salmonella Infections; Travel | 1985 |
Bismuth subsalicylate in the treatment of chronic diarrhea of childhood.
Topics: Bismuth; Body Weight; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Defecation; Diarrhea, Infantile; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infant; Male; Organometallic Compounds; Prospective Studies; Random Allocation; Salicylates | 1985 |
Prevention of traveler's diarrhea.
Topics: Bismuth; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Enterotoxins; Escherichia coli; Escherichia coli Infections; Humans; Organometallic Compounds; Salicylates; Travel | 1985 |
Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea.
Topics: Acute Disease; Adult; Antidiarrheals; Bismuth; Diarrhea; Humans; Latin America; Loperamide; Organometallic Compounds; Piperidines; Salicylates; Travel; United States | 1986 |
Travellers' diarrhoea: prevention by chemoprophylaxis.
Topics: Adult; Bismuth; Clioquinol; Diarrhea; Drug Combinations; Drug Therapy, Combination; Furazolidone; Humans; Neomycin; Organometallic Compounds; Salicylates; Streptomycin; Sulfadiazine; Sulfamethazine; Sulfathiazoles; Travel | 1983 |
Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
Topics: Antidiarrheals; Bismuth; Diarrhea; Double-Blind Method; Escherichia coli Infections; Feces; Female; Humans; Male; Organometallic Compounds; Random Allocation; Salicylates; Travel | 1983 |
Evaluation of bismuth subsalicylate in relieving symptoms of indigestion.
Topics: Adolescent; Adult; Bismuth; Clinical Trials as Topic; Digestion; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates | 1984 |
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth).
Topics: Adult; Bismuth; Clinical Trials as Topic; Diarrhea; Escherichia coli Infections; Humans; Mexico; Organometallic Compounds; Salicylates; Travel; United States | 1980 |
Influence of subsalicylate bismuth on absorption of doxycycline.
Topics: Adult; Biological Availability; Bismuth; Clinical Trials as Topic; Double-Blind Method; Doxycycline; Drug Interactions; Humans; Male; Organometallic Compounds; Random Allocation; Salicylates; Vomiting | 1982 |
Bismuth subsalicylate therapy of viral gastroenteritis.
Topics: Adolescent; Adult; Antibodies, Viral; Bismuth; Double-Blind Method; Female; Gastroenteritis; Gastrointestinal Agents; Humans; Male; Organometallic Compounds; Parvoviridae; Random Allocation; Salicylates; Virus Diseases | 1980 |
The role of location of food consumption in the prevention of travelers' diarrhea in Mexico.
Topics: Bismuth; Diarrhea; Food Contamination; Food Microbiology; Humans; Mexico; Organometallic Compounds; Placebos; Restaurants; Salicylates; Travel; United States | 1980 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients.
Topics: Adult; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Salicylates; Time Factors | 1995 |
Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
Topics: Absorption; Administration, Oral; Adult; Biological Availability; Bismuth; Ciprofloxacin; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Organometallic Compounds; Salicylates | 1994 |
Earth, wind, and fiber: is there a drug to treat acute diarrhea?
Topics: Bismuth; Diarrhea, Infantile; Dietary Fiber; Egypt; Gastrointestinal Agents; Humans; Infant; Male; Organometallic Compounds; Salicylates; Silicates | 1994 |
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
Topics: Azithromycin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Topics: Adult; Aged; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline | 1993 |
Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
Topics: Adult; Bismuth; Chronic Disease; Double-Blind Method; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Leukocyte Count; Organometallic Compounds; Salicylates; Treatment Outcome | 1993 |
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline | 1993 |
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Stomach Ulcer; Tetracycline | 1993 |
A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease.
Topics: Acute Disease; Bismuth; Body Weight; Chemotherapy, Adjuvant; Child, Preschool; Diarrhea, Infantile; Double-Blind Method; Fluid Therapy; Humans; Infant; Male; Multivariate Analysis; Organometallic Compounds; Salicylates | 1993 |
Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Penicillins; Recurrence; Salicylates | 1995 |
Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Bismuth; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastric Mucosa; Horse Diseases; Horses; Hydrogen-Ion Concentration; Magnesium Hydroxide; Male; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Salicylates; Stomach | 1996 |
Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Chile; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Salicylates; Single-Blind Method; Time Factors | 1996 |
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1996 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Dyspepsia; Evaluation Studies as Topic; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Taste Disorders | 1997 |
Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Smoking; Tetracycline; Tetracyclines | 1997 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peru; Recurrence; Salicylates; Tetracycline; Tinidazole | 1997 |
Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
Topics: Adolescent; Adult; Aluminum Compounds; Antacids; Biological Availability; Bismuth; Chromatography, High Pressure Liquid; Cross-Over Studies; Female; Humans; Intestinal Absorption; Magnesium Compounds; Male; Middle Aged; Organometallic Compounds; Regression Analysis; Salicylates; Silicates; Tetracycline | 1997 |
Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis.
Topics: Administration, Oral; Adult; Aged; Bismuth; Colitis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates; Treatment Outcome | 1998 |
Bismuth binds...
Topics: Bismuth; Colitis; Humans; Organometallic Compounds; Salicylates | 1999 |
Evaluation of effects of ethyl alcohol and bismuth subsalicylate on gastric mucosal barrier in man.
Topics: Adult; Bismuth; Ethanol; Female; Gastric Acid; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Organometallic Compounds; Salicylates | 1999 |
Garlic or jalapeño peppers for treatment of Helicobacter pylori infection.
Topics: Adult; Bismuth; Capsicum; Cross-Over Studies; Female; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Phytotherapy; Plants, Medicinal; Prospective Studies; Salicylates | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Salicylates; Treatment Outcome | 1999 |
A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Health Maintenance Organizations; Helicobacter Infections; Helicobacter pylori; Humans; Male; Massachusetts; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Program Evaluation; Salicylates; Tetracycline; Treatment Outcome | 1999 |
Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Outlet Obstruction; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Prospective Studies; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome; Urea | 2001 |
Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Epithelium; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Metronidazole; Middle Aged; Organometallic Compounds; Penicillins; Placebos; Risk Factors; Salicylates; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2001 |
Which place for bismuth subsalicylate in the treatment of enteric infections?
Topics: Acute Disease; Bismuth; Child, Preschool; Diarrhea; Gastroenteritis; Humans; Infant; Organometallic Compounds; Rehydration Solutions; Salicylates | 2001 |
The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea.
Topics: Acute Disease; Bismuth; Child, Preschool; Diarrhea; Double-Blind Method; Escherichia coli Infections; Humans; Infant; Organometallic Compounds; Rehydration Solutions; Retroviridae Infections; Salicylates | 2001 |
Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment.
Topics: Adult; Amoxicillin; Antacids; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Dyspepsia; Female; Gastric Acidity Determination; Gastritis, Atrophic; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Salicylates; Tetracycline | 2003 |
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Severity of Illness Index; Treatment Outcome | 2003 |
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Salicylates; Tetracycline; Treatment Outcome | 2004 |
Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Breath Tests; Carbon Isotopes; Citric Acid; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Salicylates; Sensitivity and Specificity; Treatment Outcome; Urea | 2005 |
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antidiarrheals; Bismuth; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline; Young Adult | 2012 |
Design, evaluation, and dissemination of a plastic syringe clip to improve dosing accuracy of liquid medications.
Topics: Administration, Oral; Adult; Antidiarrheals; Bismuth; Equipment Design; Female; Humans; Male; Organometallic Compounds; Salicylates; Syringes | 2013 |
Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Probiotics; Prognosis; Prospective Studies; Salicylates; Thailand | 2014 |
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Breath Tests; Clarithromycin; Cytochrome P-450 CYP2C19; Dexlansoprazole; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Thailand | 2015 |
Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Bismuth; Breath Tests; Clinical Protocols; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Salicylates; Turkey | 2015 |
Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Cholera; Diarrhea; Disease Outbreaks; Emergency Medical Services; Feces; Female; Fluid Therapy; Haiti; Humans; Length of Stay; Male; Organometallic Compounds; Probiotics; Saccharomyces; Salicylates; Severity of Illness Index; Treatment Outcome; Vibrio cholerae | 2015 |
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline; Young Adult | 2017 |
A Prospective, randomized study comparing 7-day and 14-day quadruple therapies as first-line treatments for helicobacter pylori infection in patients with functional dyspepsia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates | 2018 |
Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.
Topics: Adolescent; Adult; Antidiarrheals; Bismuth; Delayed-Action Preparations; Diarrhea; Dimethyl Fumarate; Double-Blind Method; Drug Therapy, Combination; Female; Flatulence; Healthy Volunteers; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Organometallic Compounds; Salicylates; Young Adult | 2018 |
Effect of Bismuth Subsalicylate vs Placebo on Use of Antibiotics Among Adult Outpatients With Diarrhea in Pakistan: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antidiarrheals; Antimicrobial Stewardship; Bismuth; Diarrhea; Drug Utilization; Female; Follow-Up Studies; Humans; Inappropriate Prescribing; Logistic Models; Male; Middle Aged; Organometallic Compounds; Pakistan; Practice Patterns, Physicians'; Salicylates; Young Adult | 2019 |
Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Esomeprazole; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Salicylates; Syria; Tinidazole; Treatment Outcome; Young Adult | 2021 |
Effects of bismuth subsalicylate and encapsulated calcium-ammonium nitrate on feedlot beef cattle production.
Topics: Animal Feed; Animals; Bismuth; Calcium; Cattle; Diet; Digestion; Nitrates; Organometallic Compounds; Rumen; Salicylates | 2021 |
225 other study(ies) available for bismuth and bismuth subsalicylate
| Article | Year |
|---|---|
Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae.
Topics: Animals; Bacterial Toxins; Bismuth; Cells, Cultured; Cholera Toxin; Enterotoxins; Escherichia coli; Ileum; Intestinal Mucosa; Organometallic Compounds; Rabbits; Salicylates; Water | 1977 |
The effect of adsorbant and anti-inflammatory drugs on secretion in ligated segments of pig intestine infected with Escherichia coli.
Topics: Animals; Anti-Inflammatory Agents; Antidiarrheals; Aspirin; Bismuth; Enterotoxins; Escherichia coli; Escherichia coli Infections; Intestinal Secretions; Jejunum; Kaolin; Ligation; Lincomycin; Methylprednisolone; Organometallic Compounds; Pectins; Polymyxin B; Salicylates; Swine; Swine Diseases | 1978 |
Use of an ammonia electrode for rapid quantification of Helicobacter pylori urease: its use in the endoscopy room and in the assessment of urease inhibition by bismuth subsalicylate.
Topics: Ammonia; Bismuth; Electrodes; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; In Vitro Techniques; Male; Middle Aged; Organometallic Compounds; Salicylates; Sensitivity and Specificity; Urease | 1992 |
Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bismuth; Drug Interactions; Microbial Sensitivity Tests; Organometallic Compounds; Pseudomonas aeruginosa; Salicylates; Salicylic Acid; Sodium Salicylate | 1992 |
Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
Topics: Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Ranitidine; Recurrence; Salicylates; Tetracycline | 1992 |
Pepto-Bismol mimicking pancreatic calcification.
Topics: Abdomen; Administration, Oral; Adult; Bismuth; Calcinosis; Diagnosis, Differential; Foreign Bodies; Humans; Male; Organometallic Compounds; Pancreatic Diseases; Radiography; Salicylates | 1992 |
Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.
Topics: Bacteria; Bismuth; Colony Count, Microbial; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Organometallic Compounds; Salicylates; Tumor Cells, Cultured | 1992 |
Deposition of bismuth by Yersinia enterocolitica.
Topics: Bismuth; Crystallization; Electron Probe Microanalysis; Microscopy, Electron, Scanning; Organometallic Compounds; Salicylates; Yersinia enterocolitica | 1992 |
Comparison of one-day oral dosing with three bismuth compounds for the suppression of Helicobacter pylori assessed by the 13C-urea breath test.
Topics: Adult; Aged; Analysis of Variance; Bismuth; Breath Tests; Carbon Dioxide; Female; Gastric Mucosa; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates; Urea; Urease | 1992 |
Factors influencing the eradication of Helicobacter pylori with triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Regression Analysis; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
Fatal salicylate toxicity from bismuth subsalicylate.
Topics: Aged; Aged, 80 and over; Bismuth; Female; Humans; Organometallic Compounds; Salicylates | 1991 |
Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Capsules; Bismuth; Drug Synergism; Gram-Negative Bacteria; Klebsiella pneumoniae; Nitrates; Organometallic Compounds; Polysaccharides, Bacterial; Salicylates; Sodium Salicylate | 1991 |
Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin.
Topics: Adult; Bismuth; Breath Tests; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitrofurantoin; Organometallic Compounds; Salicylates; Urea | 1991 |
Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Diagnosis, Differential; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Prevalence; Salicylates; Tinidazole; Urease | 1990 |
Long-term follow-up of voluntary ingestion of Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Organometallic Compounds; Recurrence; Salicylates | 1991 |
Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Dinoprostone; Duodenitis; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates | 1991 |
Helicobacter pylori.
Topics: Bismuth; Child; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Salicylates | 1991 |
Insoluble bismuth (subsalicylate) should be revived for treatment of LE in general and SCLE in particular.
Topics: Bismuth; Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Organometallic Compounds; Salicylates; Syphilis | 1991 |
For your information: traveler's diarrhea.
Topics: Bismuth; Diarrhea; Fluid Therapy; Food Microbiology; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology; Water Supply | 1991 |
Rectal bismuth subsalicylate as therapy for ulcerative colitis.
Topics: Administration, Rectal; Adolescent; Adult; Bismuth; Colitis, Ulcerative; Colon; Female; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates | 1990 |
The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate).
Topics: Adult; Bismuth; Female; Humans; Male; Organometallic Compounds; Salicylates; Salicylic Acid | 1990 |
Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbits.
Topics: Animals; Bismuth; Disease Models, Animal; Dose-Response Relationship, Drug; Esophagitis; Esophagus; Mucous Membrane; Organometallic Compounds; Pepsin A; Rabbits; Salicylates | 1990 |
Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis.
Topics: Aged; Amoxicillin; Bismuth; Campylobacter Infections; Chronic Disease; Female; Gastritis; Helicobacter pylori; Humans; Hyperplasia; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Polyps; Salicylates; Stomach; Stomach Neoplasms | 1990 |
Emporiatrics: diarrhea in travelers.
Topics: Bismuth; Campylobacter jejuni; Diarrhea; Dysentery, Bacillary; Food Contamination; Giardiasis; Humans; Organometallic Compounds; Rotavirus Infections; Salicylates; Salmonella Infections; Sulfonamides; Travel | 1990 |
Systemic chemotherapy for Helicobacter pylori eradication?
Topics: Administration, Oral; Bismuth; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Salicylates | 1990 |
Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.
Topics: Acquired Immunodeficiency Syndrome; Antidiarrheals; Bismuth; Brain Diseases; Diarrhea; Humans; Intestinal Absorption; Male; Middle Aged; Myoclonus; Organometallic Compounds; Salicylates | 1990 |
Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.
Topics: Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Female; Food; Gastrins; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline | 1990 |
Bismuth.
Topics: Bismuth; Humans; Organometallic Compounds; Salicylates; Stomatitis; Tooth Discoloration | 1990 |
Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni.
Topics: Animals; Animals, Newborn; Bismuth; Campylobacter fetus; Campylobacter Infections; Colony Count, Microbial; Diarrhea; Dose-Response Relationship, Drug; Female; Intestines; Male; Mice; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates | 1990 |
[Pharmacokinetics of bismuth preparations in patients with gastritis and ulcer disease].
Topics: Administration, Oral; Bismuth; Campylobacter Infections; Dose-Response Relationship, Drug; Gastritis; Humans; Organometallic Compounds; Salicylates; Stomach Ulcer | 1990 |
Treatment of Campylobacter pylori does not alter gastric acid secretion.
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Gastric Acid; Gastritis; Humans; Organometallic Compounds; Salicylates | 1989 |
Histopathologic findings and energy dispersive X-ray spectroscopic analysis of experimentally induced foreign-body pneumonias in rats.
Topics: Animals; Barium Sulfate; Bismuth; Drug Combinations; Electron Probe Microanalysis; Female; Kaolin; Lung; Mineral Oil; Organometallic Compounds; Pectins; Pneumonia, Aspiration; Rats; Rats, Inbred Strains; Salicylates | 1989 |
Treatment of Campylobacter gastritis in young children.
Topics: Adolescent; Amoxicillin; Bismuth; Campylobacter Infections; Child; Child, Preschool; Chronic Disease; Gastritis; Humans; Infant; Organometallic Compounds; Salicylates | 1989 |
Can bismuth decrease the kidney toxic effect of cis-platinum?
Topics: Bismuth; Cisplatin; Female; Humans; Kidney Diseases; Organometallic Compounds; Ovarian Neoplasms; Salicylates | 1989 |
[Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Salicylates | 1989 |
Binding and killing of bacteria by bismuth subsalicylate.
Topics: Adenosine Triphosphate; Bacteria; Bismuth; Campylobacter; Culture Media; Escherichia coli; Gastric Juice; Hydrogen-Ion Concentration; Organometallic Compounds; Protein Binding; Salicylates; Salmonella typhimurium; Serum Albumin; Staphylococcus aureus | 1989 |
Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
Topics: Adolescent; Adult; Aged; Bismuth; Campylobacter; Duodenitis; Dyspepsia; Endoscopy; Gastric Mucosa; Gastritis; Humans; Metronidazole; Middle Aged; Organometallic Compounds; Pyloric Antrum; Salicylates | 1989 |
Clinical experience with Campylobacter pylori in western Kentucky.
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Humans; Organometallic Compounds; Salicylates | 1989 |
The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Campylobacter; Gallic Acid; Humans; Molecular Structure; Organometallic Compounds; Salicylates | 1989 |
Pepto-bismol and salicylate levels.
Topics: Bismuth; Humans; Organometallic Compounds; Salicylates; Salicylic Acid | 1989 |
Hidden salicylates.
Topics: Bismuth; Child; Humans; Nonprescription Drugs; Organometallic Compounds; Reye Syndrome; Salicylates | 1989 |
In vivo susceptibility of Campylobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Breath Tests; Campylobacter; Campylobacter Infections; Duodenum; Humans; Organometallic Compounds; Salicylates; Stomach | 1989 |
[Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates | 1989 |
In vitro activities of bismuth salts against rotaviruses and other enteric viruses.
Topics: Animals; Bismuth; Cattle; Cells, Cultured; Enterovirus; Humans; Organometallic Compounds; Rotavirus; Salicylates; Tartrates; Viral Plaque Assay | 1985 |
Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease.
Topics: Adult; Biopsy; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Humans; Male; Middle Aged; Nitrofurantoin; Organometallic Compounds; Pilot Projects; Pyloric Antrum; Salicylates; Stomach Ulcer; Urease | 1988 |
Chronic erosive gastritis--a therapeutic approach with bismuth.
Topics: Adult; Bismuth; Campylobacter; Chronic Disease; Female; Gastritis; Gastroscopy; Humans; Male; Middle Aged; Organometallic Compounds; Pyloric Antrum; Salicylates; Stomach | 1988 |
Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
Topics: Adolescent; Ampicillin; Bismuth; Campylobacter; Campylobacter Infections; Child; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Pyloric Antrum; Salicylates | 1988 |
Stress ulcer prophylaxis and ventilation pneumonia: prevention by antibacterial cytoprotective agents?
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Gastric Juice; Humans; Hydrogen-Ion Concentration; Organometallic Compounds; Peptic Ulcer; Pneumonia; Prospective Studies; Respiration, Artificial; Risk Factors; Salicylates; Stress, Physiological; Sucralfate; Trachea | 1988 |
[Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
Topics: Adult; Aged; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Chronic Disease; Drug Evaluation; Female; Gastric Mucosa; Gastritis; Gastroscopy; Humans; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Middle Aged; Organometallic Compounds; Salicylates | 1988 |
The treatment of Campylobacter-associated gastritis.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Erythromycin; Erythromycin Ethylsuccinate; Gastritis; Humans; Organometallic Compounds; Salicylates | 1987 |
Therapy for collagenous colitis.
Topics: Adult; Antidiarrheals; Bismuth; Colitis; Humans; Male; Organometallic Compounds; Salicylates | 1987 |
In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter; Cimetidine; Humans; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates; Sucralfate | 1987 |
Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid.
Topics: Bacteria; Bismuth; Gastric Juice; Humans; Organometallic Compounds; Salicylates; Sucralfate | 1987 |
[Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Topics: Anti-Ulcer Agents; Bismuth; Campylobacter Infections; Chronic Disease; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates; Stomach Ulcer | 1987 |
Dangers from hidden salicylates.
Topics: Adolescent; Bismuth; Child; Humans; Organometallic Compounds; Reye Syndrome; Salicylates | 1986 |
Pepto-Bismal efficacy studies for diarrhea. indication submitted to FDA.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates | 1986 |
[In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].
Topics: Antacids; Bacteria; Bismuth; Feces; Fermentation; Humans; In Vitro Techniques; Intestines; Lactose; Organometallic Compounds; Salicylates | 1985 |
Travelers' diarrhea. Controversy and consensus.
Topics: Antidiarrheals; Bismuth; Diarrhea; Doxycycline; Drug Combinations; Food; Humans; Organometallic Compounds; Risk; Salicylates; Sulfamethoxazole; Terminology as Topic; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccination | 1985 |
Traveler's diarrhea: update 1983.
Topics: Bismuth; Child; Diarrhea; Doxycycline; Drug Combinations; Escherichia coli Infections; Humans; Organometallic Compounds; Premedication; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Prevention and treatment of "traveler's diarrhea".
Topics: Bismuth; Diarrhea; Doxycycline; Drug Combinations; Escherichia coli Infections; Humans; Organometallic Compounds; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.
Topics: Adsorption; Bentonite; Bile Acids and Salts; Bismuth; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; In Vitro Techniques; Organometallic Compounds; Salicylates; Solutions | 1984 |
Traveler's diarrhea.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1983 |
Traveler's diarrhea in the Mediterranean basin.
Topics: Acute Disease; Adult; Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1980 |
Risk of hypercalcemia from prophylaxis of traveler's diarrhea.
Topics: Bismuth; Diarrhea; Humans; Hypercalcemia; Organometallic Compounds; Risk; Salicylates; Travel | 1983 |
Travelers' diarrhea.
Topics: Adult; Bismuth; Child; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1983 |
Comparative evaluation of gastrointestinal blood loss in the feces of rats following Pepto-Bismol liquid and aspirin administration.
Topics: Animals; Aspirin; Bismuth; Feces; Gastrointestinal Hemorrhage; Male; Occult Blood; Organometallic Compounds; Rats; Salicylates | 1980 |
Black heme-positive stools without gastrointestinal hemorrhage.
Topics: Bismuth; Color; False Positive Reactions; Feces; Female; Gastrointestinal Hemorrhage; Heme; Humans; Infant; Organometallic Compounds; Salicylates | 1982 |
Traveler's diarrhea: must it spoil the patient's trip?
Topics: Bismuth; Diarrhea; Doxycycline; Drug Combinations; Humans; Organometallic Compounds; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Travelers' diarrhea: recent advances in prophylaxis and treatment.
Topics: Bismuth; Diarrhea; Doxycycline; Fluid Therapy; Humans; Organometallic Compounds; Salicylates; Travel | 1982 |
Encephalopathy from bismuth subsalicylate.
Topics: Bismuth; Brain Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates | 1982 |
Salicylate absorption from a bismuth subsalicylate preparation.
Topics: Adult; Bismuth; Half-Life; Humans; Intestinal Absorption; Kinetics; Male; Organometallic Compounds; Salicylates | 1981 |
Absorption of salicylate and bismuth from a bismuth subsalicylate--containing compound (Pepto-Bismol).
Topics: Adult; Bismuth; Child; Humans; Intestinal Absorption; Male; Organometallic Compounds; Salicylates | 1981 |
Preventing traveler's diarrhea.
Topics: Bismuth; Diarrhea; Doxycycline; Humans; Organometallic Compounds; Salicylates; Travel | 1981 |
Salicylate in Pepto-Bismol.
Topics: Antidiarrheals; Bismuth; Drug Interactions; Humans; Nonprescription Drugs; Organometallic Compounds; Salicylates | 1980 |
Bismuth preparations for diarrhea.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1980 |
Warning against products containing bismuth subsalicylate.
Topics: Bismuth; Gastrointestinal Diseases; Humans; Male; Organometallic Compounds; Salicylates | 1980 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Eczema responsive to treatment for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Eczema; Gastroenteritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Recurrence; Salicylates; Tetracycline | 1995 |
Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Antibodies, Bacterial; Bismuth; Child; Child, Preschool; Duodenal Ulcer; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Metronidazole; Organometallic Compounds; Polymerase Chain Reaction; Recurrence; Salicylates; Stomach Ulcer | 1995 |
Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment.
Topics: Adult; Aged; alpha-Glucosidases; Bismuth; Colitis, Ulcerative; Crohn Disease; Feces; Female; Humans; Longitudinal Studies; Male; Middle Aged; Organometallic Compounds; Salicylates; Sulfatases | 1995 |
The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
Topics: 16,16-Dimethylprostaglandin E2; Acrylic Resins; Animals; Bismuth; Duodenum; Gastric Mucosa; Intestinal Mucosa; Male; Mucus; Organometallic Compounds; Pepsin A; Peptic Ulcer; Rats; Rats, Wistar; Salicylates; Sucralfate | 1994 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
Bismuth toxicity.
Topics: Ataxia; Bismuth; Confusion; Delirium; Dyspepsia; Gait; Humans; Male; Memory Disorders; Middle Aged; Organometallic Compounds; Remission, Spontaneous; Salicylates; Tremor | 1994 |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline; Time Factors | 1994 |
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pepsinogens; Peptic Ulcer; Salicylates | 1994 |
Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
Topics: Acetaldehyde; Anti-Ulcer Agents; Bismuth; Catechols; Colloids; Depression, Chemical; Ethanol; Helicobacter pylori; Organometallic Compounds; Pentanones; Salicylates | 1994 |
Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Protein-Losing Enteropathies; Salicylates | 1994 |
H. pylori and ulcers.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1994 |
Chronic salicylate toxicity due to consumption of over-the-counter bismuth subsalicylate.
Topics: Aged; Bismuth; Female; Humans; Organometallic Compounds; Radiography, Abdominal; Salicylates | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment.
Topics: Amoxicillin; Ascorbic Acid; Bismuth; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Organometallic Compounds; Salicylates; Smoking | 1994 |
Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol)
Topics: Aged; Bismuth; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Nervous System Diseases; Organometallic Compounds; Salicylates; Substance-Related Disorders | 1993 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing.
Topics: Adult; Bismuth; Female; Food; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Peptic Ulcer; Protein Precursors; Protein Processing, Post-Translational; Salicylates; Tetracycline | 1993 |
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis.
Topics: Adult; Biopsy; Bismuth; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Organometallic Compounds; Pepsinogens; Salicylates | 1993 |
Bismuth in infants with watery diarrhea.
Topics: Bismuth; Child; Diarrhea, Infantile; Fluid Therapy; Humans; Infant; Organometallic Compounds; Salicylates | 1993 |
Bismuth in infants with watery diarrhea.
Topics: Bismuth; Child; Diarrhea, Infantile; Fluid Therapy; Humans; Infant; Organometallic Compounds; Salicylates | 1993 |
Aspirin and bismuth subsalicylate.
Topics: Aspirin; Bismuth; Child; Humans; Organometallic Compounds; Salicylates; Stomach Diseases | 1993 |
Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children.
Topics: Adolescent; Amoxicillin; Biopsy; Bismuth; Child; Child, Preschool; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Organometallic Compounds; Pyloric Antrum; Recurrence; Salicylates; Time Factors; Treatment Outcome | 1993 |
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Topics: Administration, Oral; Adult; Aged; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Salicylates; Tetracycline | 1993 |
Long-term Helicobacter pylori recurrence after successful eradication with triple therapy.
Topics: Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Recurrence; Salicylates; Tetracycline | 1993 |
Can bismuth improve the simple solution for diarrhea?
Topics: Bismuth; Diarrhea, Infantile; Fluid Therapy; Humans; Infant; Organometallic Compounds; Salicylates | 1993 |
Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin.
Topics: Administration, Oral; Animals; Antitoxins; Bismuth; Cholera Toxin; Enzyme-Linked Immunosorbent Assay; Feces; Female; Immunity, Mucosal; Immunization; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Mice; Mice, Inbred C57BL; Organometallic Compounds; Salicylates; Sodium Salicylate; Time Factors | 1995 |
Reflections on gastric ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Recurrence; Salicylates; Stomach Ulcer | 1996 |
Photo quiz. Pepto Bismol poisoning.
Topics: Bismuth; Colon; HIV Infections; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Radiography; Salicylates; Self Medication | 1996 |
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Cost of Illness; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Pilot Projects; Salicylates; Tetracycline | 1996 |
Comparative absorption of bismuth in Sprague-Dawley rats following oral administration of preparations containing bismuth sucrose octasulfate, bismuth subsalicylate, and bismuth subcitrate.
Topics: Administration, Oral; Animals; Antacids; Area Under Curve; Bismuth; Intestinal Absorption; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Spectrophotometry, Atomic; Sucrose; Tissue Distribution | 1997 |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Helicobacter pylori; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates | 1997 |
Cytoprotective effect of bismuth subsalicylate in indomethacin-treated rats is associated with enhanced mucus bismuth concentration.
Topics: Animals; Bismuth; Blood Flow Velocity; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Indomethacin; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates | 1997 |
Identification and eradication of Helicobacter pylori in an isolated patient population.
Topics: Amoxicillin; Bismuth; Cost Savings; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Military Personnel; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States; Utah | 1997 |
Black granules on the skin after bismuth subsalicylate ingestion.
Topics: Adult; Bismuth; Humans; Male; Organometallic Compounds; Salicylates; Skin | 1997 |
Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Female; Gastric Mucosa; Intestinal Mucosa; Lipid Peroxidation; Luminescent Measurements; Organometallic Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salicylates | 1997 |
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?
Topics: Adult; Antacids; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitrichomonal Agents; Bismuth; Chaperonin 60; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epithelium; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Immunohistochemistry; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline; Time Factors | 1997 |
Treatment of gastritis in cheetahs (Acinonyx jubatus).
Topics: Acinonyx; Animals; Anti-Bacterial Agents; Antitrichomonal Agents; Biopsy; Bismuth; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Gram-Negative Bacterial Infections; Helicobacter; Helicobacter Infections; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Prospective Studies; Salicylates; Sensitivity and Specificity; Tetracycline; Time Factors | 1997 |
Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets.
Topics: Amoxicillin; Animals; Antacids; Bacterial Proteins; Biopsy; Bismuth; DNA, Bacterial; Drug Therapy, Combination; Ferrets; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter; Helicobacter Infections; Metronidazole; Organometallic Compounds; Recurrence; Salicylates; Time Factors; Urease | 1996 |
Characterization and therapy for experimental infection by Helicobacter mustelae in ferrets.
Topics: Amoxicillin; Animals; Antacids; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Female; Ferrets; Gastritis; Helicobacter; Helicobacter Infections; Male; Metronidazole; Organometallic Compounds; Salicylates; Specific Pathogen-Free Organisms | 1996 |
Cure of Helicobacter pylori: a hidden curse?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Risk Factors; Salicylates; Sex Factors; Weight Gain | 1997 |
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Male; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1998 |
Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
Topics: Bismuth; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline | 1998 |
Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon.
Topics: Adult; Animals; Bismuth; Colon; Dose-Response Relationship, Drug; Feces; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Organometallic Compounds; Osmolar Concentration; Rats; Salicylates | 1998 |
Calming ulcerative colitis.
Topics: Bismuth; Colitis, Ulcerative; Humans; Hydrogen Sulfide; Organometallic Compounds; Salicylates | 1998 |
Travelers' diarrhea. Epidemiology, prevention, and self-treatment.
Topics: Antidiarrheals; Bismuth; Diarrhea; Food Microbiology; Humans; Organometallic Compounds; Salicylates; Self Care; Travel; Water Microbiology | 1998 |
Effect of pepper and bismuth subsalicylate on gastric pain and surface hydrophobicity in the rat.
Topics: Animals; Bismuth; Chemical Phenomena; Chemistry, Physical; Diet; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Male; Organometallic Compounds; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Regression Analysis; Salicylates; Spices; Stomach Diseases; Surface Properties | 1998 |
Clinical quiz. Gastrospirillum hominis.
Topics: Bacterial Infections; Bismuth; Child; Gastric Mucosa; Gastritis; Helicobacter heilmannii; Humans; Male; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 1998 |
Clostridium difficile colitis associated with treatment of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Penicillins; Salicylates; Stomach Diseases | 1998 |
The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; New York City; Organometallic Compounds; Peptic Ulcer; Prisons; Ranitidine; Retrospective Studies; Salicylates; Tetracycline; Urban Health | 1998 |
Adherence of Acinetobacter baumannii to rat bladder tissue.
Topics: Acinetobacter; Animals; Bacterial Adhesion; Bismuth; Cells, Cultured; Escherichia coli; Galactose; Humans; Mannose; Microscopy, Electron; Organometallic Compounds; Polysaccharides; Rats; Rats, Sprague-Dawley; Salicylates | 1998 |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Toxins; Bacterial Vaccines; Bismuth; Clarithromycin; Drug Therapy, Combination; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli Proteins; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Metronidazole; Omeprazole; Organometallic Compounds; Recombinant Proteins; Salicylates; Saliva; Urease | 1999 |
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Neoplasm Staging; Omeprazole; Organometallic Compounds; Prospective Studies; Remission Induction; Salicylates; Stomach Neoplasms | 1999 |
Acute and chronic stress-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate.
Topics: Animals; Bismuth; DNA Fragmentation; Female; Hydroxyl Radical; Intestinal Mucosa; Lipid Peroxidation; Organometallic Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salicylates; Stress, Physiological; Viscosity | 1999 |
Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antigens, Bacterial; Bismuth; Breath Tests; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Sensitivity and Specificity; Urea | 1999 |
Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Chronic Disease; Drug Therapy, Combination; Epidermal Growth Factor; ErbB Receptors; Female; Flow Cytometry; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates | 1999 |
Microscopic colitis syndrome: lymphocytic colitis and collagenous colitis.
Topics: Adult; Bismuth; Chronic Disease; Colitis; Colonoscopy; Diagnosis, Differential; Diarrhea; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Organometallic Compounds; Pancreatic Neoplasms; Prognosis; Salicylates; Vipoma | 1999 |
Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Disease Models, Animal; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lactose; Liver Function Tests; Macaca mulatta; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Sialic Acids | 1999 |
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; L-Lactate Dehydrogenase; Metronidazole; Omeprazole; Organometallic Compounds; Purpura, Thrombocytopenic, Idiopathic; Salicylates; Tetracycline | 1999 |
Mechanism of gastroprotection by bismuth subsalicylate against chemically induced oxidative stress in cultured human gastric mucosal cells.
Topics: Bismuth; Cells, Cultured; Cytochrome c Group; DNA Damage; DNA Fragmentation; Ethanol; Gastric Mucosa; Humans; Hydrochloric Acid; Microscopy, Confocal; Organometallic Compounds; Oxidative Stress; Reactive Oxygen Species; Salicylates; Sodium Hydroxide; Stomach; Superoxides | 1999 |
Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Chemoprevention; Colombia; Follow-Up Studies; Gastritis, Atrophic; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Penicillins; Precancerous Conditions; Salicylates; Stomach Neoplasms; Treatment Failure; Virulence | 2000 |
Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Treatment Outcome; United States | 2000 |
Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Colitis; Female; Mesalamine; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Trinitrobenzenesulfonic Acid | 2000 |
Pathophysiology and treatment of microscopic-colitis syndrome.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Cattle; Colonic Diseases, Functional; Dogs; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Rats; Salicylates; Syndrome | 2000 |
Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats.
Topics: Animals; Bismuth; Colitis; Colon; Dextran Sulfate; Feces; Hydrogen Sulfide; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Reference Values; Salicylates | 2000 |
Site of bismuth absorption from bismuth subsalicylate: implications for treatment of colonic conditions.
Topics: Absorption; Administration, Oral; Animals; Bismuth; Cecum; Colonic Diseases; Creatinine; Injections; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates | 2000 |
Collagenous colitis treated successfully with bismuth subsalicylate.
Topics: Aged; Biopsy; Bismuth; Colitis; Collagen; Colon; Female; Humans; Organometallic Compounds; Salicylates | 2000 |
Effect of EDTA on the resistance of clinical isolates of Acinetobacter baumannii to the bactericidal activity of normal human serum.
Topics: Acinetobacter; Bacterial Capsules; Bismuth; Blood Bactericidal Activity; Chelating Agents; Edetic Acid; Humans; Lipopolysaccharides; Organometallic Compounds; Salicylates | 2000 |
Acute gastroenteritis in children.
Topics: Acute Disease; Bismuth; Child; Child, Preschool; Evidence-Based Medicine; Gastroenteritis; Humans; Infant; Organometallic Compounds; Safety; Salicylates; Treatment Outcome | 2000 |
Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Ranitidine; Salicylates | 2000 |
Black tongue.
Topics: Asthma; Bismuth; Female; Gastroesophageal Reflux; Humans; Lupus Erythematosus, Systemic; Middle Aged; Organometallic Compounds; Salicylates; Tongue Diseases | 2001 |
Drug prophylaxis for travelers' diarrhea.
Topics: 4-Quinolones; Anti-Infective Agents; Antibiotic Prophylaxis; Bismuth; Diarrhea; Escherichia coli Infections; Humans; Organometallic Compounds; Probiotics; Salicylates; Travel | 2002 |
Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.
Topics: Animals; Bismuth; Disease Models, Animal; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice; Mice, Inbred C57BL; Organometallic Compounds; Salicylates; Tetracycline | 2002 |
Anaphylaxis to Pepto-Bismol.
Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Hypersensitivity; Humans; Immunoglobulin E; Male; Organometallic Compounds; Reproducibility of Results; Salicylates; Skin Tests; United States; Urticaria | 2002 |
Bismuth subsalicylate in the cecum.
Topics: Aged; Aged, 80 and over; Bismuth; Cecal Diseases; Cecum; Colonoscopy; Female; Humans; Organometallic Compounds; Radiography, Abdominal; Salicylates; Treatment Outcome | 2002 |
Towards a molecular model for bismuth(III) subsalicylate. Synthesis and solid-state structure of [Bi(Hsal)3(bipy)(C7H8]2 and [Bi(Hsal)(sal)(1,10-phenanthroline)(C7H8]2.
Topics: Amines; Bismuth; Ligands; Models, Molecular; Molecular Structure; Organometallic Compounds; Phenanthrolines; Salicylates | 2002 |
[Treatment of collagenous colitis. An analysis of a systematic Cochrane review].
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2003 |
Treatment of early syphilis with penicillin and bismuth subsalicylate: daily injection of 500,000 units of penicillin G in sodium chloride solution for twenty consecutive days and ten to twenty doses of bismuth subsalicylate at the rate of two a week; sec
Topics: Antacids; Bismuth; Organometallic Compounds; Penicillin G; Penicillins; Salicylates; Sodium Chloride; Syphilis | 1950 |
Penicillin in the treatment of experimental syphilis of rabbits. VII. Penicillin "S-R" and procaine penicillin G in peanut oil with aluminum monostearate, alone and in combination with oxophenarsine hydrochloride (mapharsen) or bismuth subsalicylate.
Topics: Animals; Arsenicals; Bismuth; Organometallic Compounds; Peanut Oil; Penicillin G Procaine; Penicillins; Plant Oils; Rabbits; Salicylates; Stearic Acids; Syphilis | 1951 |
Adsorption characteristics of aureomycin and terramycin on aluminum hydroxide gel and on a bismuth subsalicylate preparation.
Topics: Adsorption; Aluminum Hydroxide; Antacids; Antidiarrheals; Bismuth; Chlortetracycline; Organometallic Compounds; Oxytetracycline; Salicylates | 1952 |
The treatment of early syphilis with penicillin and bismuth subsalicylate; follow-up report.
Topics: Antacids; Antidiarrheals; Bismuth; Follow-Up Studies; Organometallic Compounds; Penicillins; Salicylates; Syphilis | 1952 |
Bismuth subsalicylate increases intracellular Ca2+, MAP-kinase activity, and cell proliferation in normal human gastric mucous epithelial cells.
Topics: Acetates; Bismuth; Blotting, Western; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Flavonoids; Gastric Mucosa; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Organometallic Compounds; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Calcium-Sensing; Salicylates; Signal Transduction | 2004 |
Treatment of early syphilis with penicillin and bismuth subsalicylate; daily injection of 500,000 units of penicillin G in sodium chloride solution for 20 consecutive days and 10 to 20 doses of bismuth subsalicylate at the rate of two a week.
Topics: Antacids; Bismuth; Organometallic Compounds; Penicillin G; Penicillins; Salicylates; Sodium Chloride; Syphilis | 1950 |
Tryparsamide and bismuth subsalicylate in the treatment of experimental syphilis of rabbits; synergistic or additive activity.
Topics: Animals; Antacids; Arsenicals; Bismuth; Organometallic Compounds; Rabbits; Salicylates; Syphilis | 1950 |
Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Beverages; Bismuth; Clostridioides difficile; Drug Interactions; Fruit; Humans; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates; Sulfhydryl Compounds | 2005 |
Metabolism of bismuth subsalicylate and intracellular accumulation of bismuth by Fusarium sp. strain BI.
Topics: Biomass; Bismuth; Culture Media; Fusarium; Glucose; Microscopy, Electron, Transmission; Molecular Sequence Data; Organometallic Compounds; Peptide Elongation Factor 1; RNA, Ribosomal, 18S; Salicylates; Sequence Analysis, DNA; Tubulin | 2005 |
Managing diarrhea in infants.
Topics: Bismuth; Diarrhea, Infantile; Fluid Therapy; Humans; Infant; Organometallic Compounds; Salicylates | 2005 |
[Plant sulfate assimilation and regulation of the activity of related enzymes under cadmium stress].
Topics: Bismuth; Cadmium; Gene Expression Regulation, Plant; Organometallic Compounds; Oxidoreductases Acting on Sulfur Group Donors; Phytochelatins; Plants; Salicylates; Sulfate Adenylyltransferase; Sulfates | 2006 |
Salicylate toxicity associated with administration of Percy medicine in an infant.
Topics: Bismuth; Colic; Humans; Infant; Male; Organometallic Compounds; Salicylates | 2006 |
Pityriasis rosea-like eruption due to bismuth.
Topics: Aged; Bismuth; Diagnosis, Differential; Drug Eruptions; Female; Humans; Organometallic Compounds; Pityriasis Rosea; Salicylates | 2006 |
Can I prevent travelers' diarrhea by taking antibiotics before my trip?
Topics: Antibiotic Prophylaxis; Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 2006 |
Towards a structural understanding of the anti-ulcer and anti-gastritis drug bismuth subsalicylate.
Topics: Anti-Ulcer Agents; Bismuth; Crystallography, X-Ray; Gastritis; Models, Molecular; Molecular Structure; Organometallic Compounds; Salicylates | 2006 |
Find out what's behind that fuzzy-looking, black tongue.
Topics: Bismuth; Dentists; Drug-Related Side Effects and Adverse Reactions; Humans; Mouth Diseases; Organometallic Compounds; Professional Role; Salicylates; Tongue, Hairy | 2006 |
Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Retrospective Studies; Salicylates; Treatment Outcome | 2006 |
What is your diagnosis? A bismuth subsalicylate tablet in the stomach.
Topics: Animals; Bismuth; Chelating Agents; Dog Diseases; Dogs; Female; Foreign Bodies; Organometallic Compounds; Radiography, Abdominal; Salicylates; Tablets; Treatment Outcome; Vomiting | 2007 |
Cooperative influence of thiolate ligands on the bio-relevant coordination chemistry of bismuth.
Topics: Amino Acids; Bismuth; Cysteine; Glycine; Molecular Structure; Organometallic Compounds; Picolinic Acids; Salicylates; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds | 2007 |
Case of the month. Obstipation.
Topics: Abdominal Pain; Adult; Bismuth; Constipation; Fecal Impaction; Humans; Male; Organometallic Compounds; Radiography; Salicylates | 2007 |
Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Colombia; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Organometallic Compounds; Precancerous Conditions; Regression Analysis; Salicylates; Smoking; Treatment Failure | 2007 |
The effect of starvation stress on the protein profiles in Flexibacter chinensis.
Topics: Amino Acid Sequence; Bacterial Proteins; Bismuth; Carbon; Electrophoresis, Gel, Two-Dimensional; Escherichia coli; Flexibacter; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Nitrogen; Organometallic Compounds; Oxidative Stress; Phosphates; Salicylates; Temperature; Time Factors | 2008 |
[Topic: Treating travelers' diarrhea. When should medication be given?].
Topics: Adult; Anti-Bacterial Agents; Antidiarrheals; Atropine; Bismuth; Child; Cross-Sectional Studies; Diarrhea; Diphenoxylate; Drug Combinations; Dysentery; Fluid Therapy; Fluoroquinolones; Humans; Loperamide; Organometallic Compounds; Probiotics; Risk Factors; Salicylates; Travel | 2008 |
Mucosal tear in collagenous colitis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antidiarrheals; Biopsy; Bismuth; Budesonide; Ciprofloxacin; Colitis, Collagenous; Colonoscopy; Enema; Female; Humans; Intestinal Mucosa; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Treatment Outcome | 2009 |
Notched stress-strain behavior of a conventional and a sequentially annealed highly crosslinked UHMWPE.
Topics: Biocompatible Materials; Bismuth; Compressive Strength; Cross-Linking Reagents; Materials Testing; Organometallic Compounds; Polyethylenes; Prostheses and Implants; Salicylates; Tensile Strength | 2008 |
Characterization of an outbreak of astroviral diarrhea in a group of cheetahs (Acinonyx jubatus).
Topics: Acinonyx; Animals; Antidiarrheals; Astroviridae; Astroviridae Infections; Base Sequence; Bismuth; Capsid Proteins; Disease Outbreaks; Feces; Female; Microscopy, Electron, Transmission; Molecular Sequence Data; Organometallic Compounds; Phylogeny; Reverse Transcriptase Polymerase Chain Reaction; RNA-Dependent RNA Polymerase; RNA, Viral; Salicylates; Vipoma | 2009 |
[Effects of fluid shear stress time on carbonic anhydrase in rat osteoclasts].
Topics: Animals; Bismuth; Carbonic Anhydrases; Cells, Cultured; Organometallic Compounds; Osteoclasts; Rats; RNA, Messenger; Salicylates; Stress, Mechanical | 2009 |
Crohn's colitis with perianal disease complicated by collagenous colitis: discourse on management options.
Topics: Antidiarrheals; Bismuth; Colitis; Colitis, Collagenous; Crohn Disease; Drug Therapy, Combination; Female; Humans; Loperamide; Middle Aged; Organometallic Compounds; Psychoses, Substance-Induced; Rectal Fistula; Salicylates; Steroids | 2010 |
The kaopectate-paregoric incompatibility.
Topics: Bismuth; Humans; Opium; Organometallic Compounds; Salicylates; Stomach | 1947 |
The relative toxicity and therapeutic activity in experimental syphilis of bismuth subsalicylate, bismosol, and biliposol.
Topics: Bismuth; Organometallic Compounds; Salicylates; Syphilis | 1946 |
Tissue necrosis from injection of bismuth subsalicylate in vegetable oil.
Topics: Antacids; Antidiarrheals; Bismuth; Humans; Injections; Organometallic Compounds; Plant Oils; Salicylates | 1946 |
Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Humans; Organometallic Compounds; Proton Pump Inhibitors; Salicylates | 2010 |
Bismuth subsalicylate in oil; the treatment of choice in Vincent's angina.
Topics: Bismuth; Fusobacterium Infections; Gingivitis, Necrotizing Ulcerative; Organometallic Compounds; Salicylates | 1946 |
Bismuth subsalicylate in oil the treatment of choice in Vincent's angina.
Topics: Antacids; Bismuth; Fusobacterium Infections; Gingivitis, Necrotizing Ulcerative; Organometallic Compounds; Salicylates | 1946 |
Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Bismuth; Cathelicidins; Cell Wall; Cholesterol; DNA Replication; Drug Resistance, Bacterial; Folic Acid; Helicobacter pylori; Hydrophobic and Hydrophilic Interactions; Lipid A; Monomeric GTP-Binding Proteins; Organometallic Compounds; Phosphoric Monoester Hydrolases; Protein Synthesis Inhibitors; Salicylates | 2011 |
Mechanosynthesis of the metallodrug bismuth subsalicylate from Bi2O3 and structure of bismuth salicylate without auxiliary organic ligands.
Topics: Bismuth; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Organometallic Compounds; Salicylates | 2011 |
In vivo differentiation of complementary contrast media at dual-energy CT.
Topics: Administration, Oral; Animals; Bismuth; Contrast Media; Feasibility Studies; Image Processing, Computer-Assisted; Injections, Intravenous; Iohexol; Organometallic Compounds; Phantoms, Imaging; Rabbits; Salicylates; Tomography, X-Ray Computed; Tungsten Compounds | 2012 |
Single-site bismuth alkoxide catalysts for the ring-opening polymerization of lactide.
Topics: Bismuth; Catalysis; Coordination Complexes; Crystallography, X-Ray; Dioxanes; Ethylenediamines; Kinetics; Molecular Conformation; Organometallic Compounds; Polyesters; Salicylates | 2013 |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Chlorides; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Peptic Ulcer; Salicylates; Zinc Compounds | 2014 |
Bismuth salicylate for diarrhea in children.
Topics: Antidiarrheals; Bismuth; Child; Cost-Benefit Analysis; Developing Countries; Diarrhea; Evidence-Based Medicine; Humans; Organometallic Compounds; Reye Syndrome; Salicylates | 2013 |
Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy.
Topics: Anticoagulants; Bismuth; Drug Interactions; Enteral Nutrition; Female; Humans; International Normalized Ratio; Middle Aged; Organometallic Compounds; Salicylates; Warfarin | 2013 |
Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: role of nitric oxide and hydrogen sulfide.
Topics: Adipose Tissue; Alkynes; Animals; Biological Factors; Bismuth; Cystathionine gamma-Lyase; Diet; Endothelium, Vascular; Gene Expression Regulation; Glycine; Hydrogen Sulfide; Leptin; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Organometallic Compounds; Phenylephrine; Rats; Rats, Wistar; Receptors, Leptin; Salicylates; Signal Transduction; Tissue Culture Techniques; Vasoconstriction; Vasodilation | 2014 |
Renal pigmentation due to chronic bismuth administration in a rhesus macaque (Macaca mulatta).
Topics: Animals; Antiemetics; Bismuth; Kidney; Kidney Diseases; Macaca mulatta; Male; Monkey Diseases; Organometallic Compounds; Pigmentation; Pigmentation Disorders; Salicylates; Vomiting | 2015 |
What is your diagnosis? Obstructive intestinal foreign body.
Topics: Animals; Bismuth; Dog Diseases; Dogs; Foreign Bodies; Intestinal Obstruction; Male; Organometallic Compounds; Salicylates; Tablets; Textiles | 2015 |
Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.
Topics: Animals; Anti-Infective Agents; Bacterial Load; Bismuth; Clostridioides difficile; Enterobacteriaceae; Humans; Mice; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Norovirus; Organometallic Compounds; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Salicylates; Viral Load; Viral Plaque Assay | 2015 |
Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Female; Humans; Logistic Models; Male; Middle Aged; Organometallic Compounds; Salicylates; Tertiary Care Centers; Treatment Outcome | 2015 |
Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area.
Topics: Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prognosis; Salicylates; Thailand | 2015 |
Mitigation of in vitro hydrogen sulfide production using bismuth subsalicylate with and without monensin in beef feedlot diets.
Topics: Animal Feed; Animals; Bismuth; Cattle; Diet; Digestion; Fermentation; Hydrogen; Hydrogen Sulfide; Monensin; Organometallic Compounds; Rumen; Salicylates | 2015 |
Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Canada; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Salvage Therapy; Tetracycline; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
Sulfate-reducing bacteria slow intestinal transit in a bismuth-reversible fashion in mice.
Topics: Animals; Bismuth; Desulfovibrio vulgaris; Female; Gastrointestinal Transit; Hydrogen Sulfide; Intestine, Small; Mice; Mice, Inbred C57BL; Organometallic Compounds; Random Allocation; Salicylates | 2017 |
Barry Marshall, MD: H pylori 35 Years Later.
Topics: Anniversaries and Special Events; Antacids; Anti-Bacterial Agents; Asthma; Bacterial Vaccines; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nobel Prize; Organometallic Compounds; Peptic Ulcer; Probiotics; Salicylates; Stress, Psychological | 2017 |
Case 1: Mysteriously Rising Salicylate Levels in a 15-year-old Girl.
Topics: Adolescent; Bezoars; Biomarkers; Bismuth; Female; Humans; Organometallic Compounds; Radiography; Salicylates; Stomach; Suicide, Attempted | 2017 |
Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications.
Topics: Aggregatibacter actinomycetemcomitans; Anaerobiosis; Anti-Bacterial Agents; Bismuth; Cell Line; Cell Survival; Drug Compounding; Fibroblasts; Gingiva; Humans; L-Lactate Dehydrogenase; Microbial Sensitivity Tests; Nanoparticles; Organometallic Compounds; Porphyromonas gingivalis; Salicylates | 2017 |
Lymphocytic colitis: pathologic predictors of response to therapy.
Topics: Adult; Aged; Aged, 80 and over; Antidiarrheals; Biopsy; Bismuth; Colitis, Lymphocytic; Collagen; Female; Humans; Male; Mesalamine; Middle Aged; Organometallic Compounds; Salicylates; Steroids; Treatment Outcome | 2018 |
Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Doxycycline; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell; Metronidazole; Middle Aged; Organometallic Compounds; Rabeprazole; Salicylates | 2018 |
Bismuth Subsalicylate Coagulopathy in a Patient with Chronic Liver Disease.
Topics: Bismuth; Blood Coagulation Disorders; Chronic Disease; Female; Humans; International Normalized Ratio; Liver Cirrhosis; Middle Aged; Organometallic Compounds; Salicylates | 2019 |
Bismuth encephalopathy- a rare complication of long-standing use of bismuth subsalicylate.
Topics: Adult; Bismuth; Brain Diseases; Female; Humans; Neurotoxicity Syndromes; Organometallic Compounds; Salicylates | 2019 |
Mucoadhesive effect of Curcuma longa extract and curcumin decreases the ranitidine effect, but not bismuth subsalicylate on ethanol-induced ulcer model.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Curcuma; Curcumin; Disease Models, Animal; Drug Interactions; Ethanol; Gastric Mucosa; Herb-Drug Interactions; Male; Organometallic Compounds; Plant Extracts; Ranitidine; Rats; Rats, Wistar; Salicylates; Stomach Ulcer | 2019 |
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
Topics: Aged, 80 and over; Anemia; Antidiarrheals; Betacoronavirus; Bismuth; Blood Sedimentation; C-Reactive Protein; Coronavirus Infections; Cough; COVID-19; Crohn Disease; Diarrhea; Humans; Lymphopenia; Male; Organometallic Compounds; Pandemics; Pneumonia, Viral; Salicylates; SARS-CoV-2; Treatment Outcome | 2020 |
Use of the Multiplex Diagnostic PCR Panel in Diarrheal Disease: Expert Guidance on the Interpretation of Results With a Focus on Travelers' Diarrhea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Antiprotozoal Agents; Bismuth; Campylobacter Infections; Dysentery; Enteropathogenic Escherichia coli; Escherichia coli; Escherichia coli Infections; Giardiasis; Humans; Loperamide; Multiplex Polymerase Chain Reaction; Organometallic Compounds; Salicylates; Shiga-Toxigenic Escherichia coli; Travel-Related Illness | 2020 |
Effects of bismuth subsalicylate and encapsulated calcium ammonium nitrate on ruminal fermentation of beef cattle.
Topics: Animal Feed; Animals; Bismuth; Cattle; Diet; Dietary Supplements; Digestion; Fermentation; Male; Molasses; Nitrates; Nitrogen; Organometallic Compounds; Paspalum; Quaternary Ammonium Compounds; Rumen; Saccharum; Salicylates; Urea | 2020 |
Effects of bismuth subsalicylate and encapsulated calcium-ammonium nitrate on enteric methane production, nutrient digestibility, and liver mineral concentration of beef cattle.
Topics: Animal Feed; Animals; Bismuth; Cattle; Diet; Dietary Supplements; Digestion; Female; Gastrointestinal Tract; Liver; Male; Methane; Minerals; Molasses; Nitrates; Nutrients; Organometallic Compounds; Paspalum; Quaternary Ammonium Compounds; Random Allocation; Saccharum; Salicylates; Urea | 2020 |
Salicylate toxicity from chronic bismuth subsalicylate use.
Topics: Accidental Falls; Aged; Bismuth; Confusion; Diagnosis, Differential; Hearing Disorders; Humans; Male; Organometallic Compounds; Salicylates | 2020 |
Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Drug Combinations; Drug Interactions; Magnesium Hydroxide; Male; Moxifloxacin; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Weightlessness; Weightlessness Simulation | 2021 |
74-Year-Old Woman With Chronic Diarrhea.
Topics: Aged; Antidiarrheals; Bismuth; Chronic Disease; Colitis, Microscopic; Diagnosis, Differential; Diarrhea; Female; Humans; Intestinal Mucosa; Organometallic Compounds; Salicylates | 2021 |
Bismuth subsalicylate incorporated in polycaprolactone-gelatin membranes by electrospinning to prevent bacterial colonization.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bismuth; Cell Survival; Cells, Cultured; Electrochemical Techniques; Fibroblasts; Gelatin; Gingiva; Guided Tissue Regeneration, Periodontal; Humans; Membranes, Artificial; Organometallic Compounds; Polyesters; Salicylates | 2021 |
Real-Time Observation of "Soft" Magic-Size Clusters during Hydrolysis of the Model Metallodrug Bismuth Disalicylate.
Topics: Bismuth; Organometallic Compounds; Salicylates | 2021 |
Structure of the active pharmaceutical ingredient bismuth subsalicylate.
Topics: Bismuth; Helicobacter Infections; Humans; Organometallic Compounds; Pharmaceutical Preparations; Salicylates | 2022 |
Bismuth Subsalicylate Poisoning.
Topics: Bismuth; Humans; Organometallic Compounds; Salicylates | 2022 |
Dual-Energy CT Reveals Bismuth Subsalicylate Overdose in Acute Appendicitis.
Topics: Acute Disease; Appendicitis; Bismuth; Humans; Salicylates; Tomography, X-Ray Computed | 2023 |